BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46. [PMID: 20022810 DOI: 10.1016/S1470-2045(09)70343-2] [Cited by in Crossref: 567] [Cited by in F6Publishing: 381] [Article Influence: 43.6] [Reference Citation Analysis]
Number Citing Articles
1 Xu G, Li N, Zhang Y, Zhang J, Xu R, Wu Y. MicroRNA-383-5p inhibits the progression of gastric carcinoma via targeting HDAC9 expression. Braz J Med Biol Res 2019;52:e8341. [PMID: 31365693 DOI: 10.1590/1414-431X20198341] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
2 Wang AM, Huang TT, Hsu KW, Huang KH, Fang WL, Yang MH, Lo SS, Chi CW, Lin JJ, Yeh TS. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 2014;5:5002-16. [PMID: 24970812 DOI: 10.18632/oncotarget.2073] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
3 Shi DB, Ma RR, Zhang H, Hou F, Guo XY, Gao P. GAGE7B promotes tumor metastasis and growth via activating the p38δ/pMAPKAPK2/pHSP27 pathway in gastric cancer. J Exp Clin Cancer Res 2019;38:124. [PMID: 30871606 DOI: 10.1186/s13046-019-1125-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Tong F, Cao P, Yin Y, Xia S, Lai R, Liu S. MicroRNAs in gastric cancer: from benchtop to bedside. Dig Dis Sci. 2014;59:24-30. [PMID: 24114043 DOI: 10.1007/s10620-013-2887-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
5 Huang KH, Lan YT, Fang WL, Chen JH, Lo SS, Li AF, Chiou SH, Wu CW, Shyr YM. The correlation between miRNA and lymph node metastasis in gastric cancer. Biomed Res Int 2015;2015:543163. [PMID: 25688358 DOI: 10.1155/2015/543163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
6 Neo SH, Chung KY, Quek JM, Too HP. Trehalose significantly enhances the recovery of serum and serum exosomal miRNA from a paper-based matrix. Sci Rep 2017;7:16686. [PMID: 29192155 DOI: 10.1038/s41598-017-16960-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
7 Shen L, Chen XD, Zhang YH. MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN. Tumour Biol 2014;35:2069-74. [PMID: 24132591 DOI: 10.1007/s13277-013-1274-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
8 Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, Khan MA, Bowman ED, Mueller A, Schad A, Shimomura M. High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int J Cancer. 2014;134:1926-1934. [PMID: 24122631 DOI: 10.1002/ijc.28522] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
9 Liu Y, Li R, Liang F, Deng C, Seidi F, Xiao H. Fluorescent paper-based analytical devices for ultra-sensitive dual-type RNA detections and accurate gastric cancer screening. Biosens Bioelectron 2022;197:113781. [PMID: 34781178 DOI: 10.1016/j.bios.2021.113781] [Reference Citation Analysis]
10 Shen ZY, Zhang ZZ, Liu H, Zhao EH, Cao H. miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med. 2014;7:1757-1761. [PMID: 24926380 DOI: 10.3892/etm.2014.1627] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
11 Di Leva G, Croce CM. Roles of small RNAs in tumor formation. Trends Mol Med. 2010;16:257-267. [PMID: 20493775 DOI: 10.1016/j.molmed.2010.04.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 171] [Article Influence: 14.3] [Reference Citation Analysis]
12 Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021;9:1448. [PMID: 34680565 DOI: 10.3390/biomedicines9101448] [Reference Citation Analysis]
13 Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, Wenham RM, Nicosia SV, Lancaster JM, Sellers TA, Cheng JQ. MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J Biol Chem 2012;287:34970-8. [PMID: 22927443 DOI: 10.1074/jbc.M112.374611] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 9.1] [Reference Citation Analysis]
14 Goto K, Oue N, Shinmei S, Sentani K, Sakamoto N, Naito Y, Hayashi T, Teishima J, Matsubara A, Yasui W. Expression of miR-486 is a potential prognostic factor after nephrectomy in advanced renal cell carcinoma. Mol Clin Oncol 2013;1:235-40. [PMID: 24649153 DOI: 10.3892/mco.2012.46] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
15 Chira P, Vareli K, Sainis I, Papandreou C, Briasoulis E. Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value. Cancers (Basel) 2010;2:1328-53. [PMID: 24281118 DOI: 10.3390/cancers2021328] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
16 Ferracin M, Bassi C, Pedriali M, Pagotto S, D'Abundo L, Zagatti B, Corrà F, Musa G, Callegari E, Lupini L, Volpato S, Querzoli P, Negrini M. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression. Mol Cancer 2013;12:130. [PMID: 24165569 DOI: 10.1186/1476-4598-12-130] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
17 Yanokura M, Banno K, Kobayashi Y, Nomura H, Hayashi S, Tominaga E, Aoki D. Recent findings on epigenetic gene abnormalities involved in uterine cancer. Mol Clin Oncol 2017;7:733-7. [PMID: 29181164 DOI: 10.3892/mco.2017.1428] [Reference Citation Analysis]
18 Azarbarzin S, Feizi MA, Safaralizadeh R, Kazemzadeh M, Fateh A. The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer. Biochem Genet. 2017;55:244-252. [PMID: 28243881 DOI: 10.1007/s10528-017-9793-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
19 Liang H, Kim YH. Identifying molecular drivers of gastric cancer through next-generation sequencing. Cancer Lett 2013;340:241-6. [PMID: 23178814 DOI: 10.1016/j.canlet.2012.11.029] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
20 Gu S, Cheung HH, Lee TL, Lu G, Poon WS, Chan WY. Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas. PLoS One 2013;8:e83980. [PMID: 24391856 DOI: 10.1371/journal.pone.0083980] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
21 Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett. 2013;329:125-136. [PMID: 23196059 DOI: 10.1016/j.canlet.2012.11.001] [Cited by in Crossref: 153] [Cited by in F6Publishing: 153] [Article Influence: 15.3] [Reference Citation Analysis]
22 Xiong X, Ren HZ, Li MH, Mei JH, Wen JF, Zheng CL. Down-regulated miRNA-214 induces a cell cycle G1 arrest in gastric cancer cells by up-regulating the PTEN protein. Pathol Oncol Res 2011;17:931-7. [PMID: 21688200 DOI: 10.1007/s12253-011-9406-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
23 Zhou N, Qu Y, Xu C, Tang Y. Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2. Exp Ther Med. 2016;11:625-630. [PMID: 26893657 DOI: 10.3892/etm.2015.2920] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
24 Suárez-Arriaga MC, Ribas-Aparicio RM, Ruiz-Tachiquín ME. MicroRNAs in hereditary diffuse gastric cancer. Biomed Rep 2016;5:151-4. [PMID: 27446532 DOI: 10.3892/br.2016.706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
25 Song X, Zhong H, Wu Q, Wang M, Zhou J, Zhou Y, Lu X, Ying B. Association between SNPs in microRNA machinery genes and gastric cancer susceptibility, invasion, and metastasis in Chinese Han population. Oncotarget 2017;8:86435-46. [PMID: 29156806 DOI: 10.18632/oncotarget.21199] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
26 Schmitz M, Driesch C, Jansen L, Runnebaum IB, Dürst M. Non-random integration of the HPV genome in cervical cancer. PLoS One 2012;7:e39632. [PMID: 22761851 DOI: 10.1371/journal.pone.0039632] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 8.7] [Reference Citation Analysis]
27 Hazarika S, Farber CR, Dokun AO, Pitsillides AN, Wang T, Lye RJ, Annex BH. MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway. Circulation 2013;127:1818-28. [PMID: 23559675 DOI: 10.1161/CIRCULATIONAHA.112.000860] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
28 Wang J, Zhang M, Hu X, She J, Sun R, Qin S, Li D. miRNA-194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1. FEBS Open Bio 2021;11:1814-26. [PMID: 33605558 DOI: 10.1002/2211-5463.13125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Kim BK, Kim I, Lee AR, Yoo HI, Yoon SK. Mouse-specific up-regulation of Ccnb1 expression by miR-199a-5p in keratinocyte. FEBS Open Bio 2016;6:1131-40. [PMID: 27833853 DOI: 10.1002/2211-5463.12133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Li H, Zhang K, Liu LH, Ouyang Y, Guo HB, Zhang H, Bu J, Xiao T. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncol Lett 2015;10:1662-8. [PMID: 26622728 DOI: 10.3892/ol.2015.3378] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
31 Li X, Dong W, Qu X, Zhao H, Wang S, Hao Y, Li Q, Zhu J, Ye M, Xiao W. Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data. Oncol Lett 2017;13:3177-85. [PMID: 28521423 DOI: 10.3892/ol.2017.5798] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Li C, Song L, Zhang Z, Bai XX, Cui MF, Ma LJ. MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression. Oncotarget 2016;7:66989-7003. [PMID: 27611950 DOI: 10.18632/oncotarget.11888] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
33 Zhao X, Hou Y, Tuo Z, Wei F. Application values of miR-194 and miR-29 in the diagnosis and prognosis of gastric cancer. Exp Ther Med 2018;15:4179-84. [PMID: 29725366 DOI: 10.3892/etm.2018.5931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
34 Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2011;53:26-33. [PMID: 21546856 DOI: 10.1097/mpg.0b013e31822200cc] [Cited by in Crossref: 107] [Cited by in F6Publishing: 65] [Article Influence: 9.7] [Reference Citation Analysis]
35 Cai H, Xu J, Han Y, Lu Z, Han T, Ding Y, Ma L. Integrated miRNA-risk gene-pathway pair network analysis provides prognostic biomarkers for gastric cancer. Onco Targets Ther 2016;9:2975-86. [PMID: 27284247 DOI: 10.2147/OTT.S95129] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
36 Chen J, Hu B, Wang W, Qian XJ, Shan BJ, He YF. A six-microRNA signature to predict outcomes of patients with gastric cancer. FEBS Open Bio 2019;9:538-47. [PMID: 30868062 DOI: 10.1002/2211-5463.12593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Shrestha S, Hsu SD, Huang WY, Huang HY, Chen W, Weng SL, Huang HD. A systematic review of microRNA expression profiling studies in human gastric cancer. Cancer Med. 2014;3:878-888. [PMID: 24902858 DOI: 10.1002/cam4.246] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 11.3] [Reference Citation Analysis]
38 Zhang Z, Dai DQ. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation. World J Gastroenterol 2019; 25(10): 1224-1237 [PMID: 30886505 DOI: 10.3748/wjg.v25.i10.1224] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
39 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
40 Wu HH, Lin WC, Tsai KW. Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med. 2014;16:e1. [PMID: 24456939 DOI: 10.1017/erm.2013.16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 103] [Article Influence: 12.6] [Reference Citation Analysis]
41 Jin Y, Zhang F, Ma Z, Ren Z. MicroRNA 433 regulates nonsense-mediated mRNA decay by targeting SMG5 mRNA. BMC Mol Biol 2016;17:17. [PMID: 27473591 DOI: 10.1186/s12867-016-0070-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
42 Yao L, Shi W, Gu J. Micro-RNA 205-5p is Involved in the Progression of Gastric Cancer and Targets Phosphatase and Tensin Homolog (PTEN) in SGC-7901 Human Gastric Cancer Cells. Med Sci Monit 2019;25:6367-77. [PMID: 31444971 DOI: 10.12659/MSM.915970] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ma M, Zhang Y, Weng M, Hu Y, Xuan Y, Hu Y, Lv K. lncRNA GCAWKR Promotes Gastric Cancer Development by Scaffolding the Chromatin Modification Factors WDR5 and KAT2A. Mol Ther 2018;26:2658-68. [PMID: 30274785 DOI: 10.1016/j.ymthe.2018.09.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
44 Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, Zhou H, Xun Q. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 2014;9:e90810. [PMID: 24595016 DOI: 10.1371/journal.pone.0090810] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
45 Fischer AS, Sigal M. The Role of Wnt and R-spondin in the Stomach During Health and Disease. Biomedicines 2019;7:E44. [PMID: 31248166 DOI: 10.3390/biomedicines7020044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
46 Gao L, Li J, He J, Liang L, He Z, Yue C, Jin X, Luo G, Zhou Y. CD90 affects the biological behavior and energy metabolism level of gastric cancer cells by targeting the PI3K/AKT/HIF-1α signaling pathway. Oncol Lett 2021;21:191. [PMID: 33574930 DOI: 10.3892/ol.2021.12451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Guo Y, Qi Y, Guo A, Du C, Zhang R, Chu X. miR-564 is downregulated in gastric carcinoma and targets E2F3. Oncol Lett 2017;13:4155-60. [PMID: 28588702 DOI: 10.3892/ol.2017.5964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
48 Han TS, Hur K, Xu G, Choi B, Okugawa Y, Toiyama Y, Oshima H, Oshima M, Lee HJ, Kim VN, Chang AN, Goel A, Yang HK. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut. 2015;64:203-214. [PMID: 24870620 DOI: 10.1136/gutjnl-2013-306640] [Cited by in Crossref: 91] [Cited by in F6Publishing: 93] [Article Influence: 11.4] [Reference Citation Analysis]
49 Guo SL, Peng Z, Yang X, Fan KJ, Ye H, Li ZH, Wang Y, Xu XL, Li J, Wang YL, Teng Y, Yang X. miR-148a promoted cell proliferation by targeting p27 in gastric cancer cells. Int J Biol Sci 2011;7:567-74. [PMID: 21552422 DOI: 10.7150/ijbs.7.567] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
50 Wang M, Zhao C, Shi H, Zhang B, Zhang L, Zhang X, Wang S, Wu X, Yang T, Huang F. Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br J Cancer. 2014;110:1199-1210. [PMID: 24473397 DOI: 10.1038/bjc.2014.14] [Cited by in Crossref: 120] [Cited by in F6Publishing: 129] [Article Influence: 15.0] [Reference Citation Analysis]
51 Dou D, Li XK, Xia QS, Chen YY, Li YL, Wang C, Qi ZR, Tan HY. Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms. BMC Gastroenterol 2021;21:188. [PMID: 33892648 DOI: 10.1186/s12876-021-01769-7] [Reference Citation Analysis]
52 Zhu D, Sun Y, Zhang D, Dong M, Jiang G, Zhang X, Zhou J. miR‑1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor. Oncol Rep 2018;40:589-98. [PMID: 29845255 DOI: 10.3892/or.2018.6463] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
53 Bhat SA, Majid S, Rehman MU. Scenario and future prospects of microRNAs in gastric cancer: A review. Iran J Basic Med Sci 2019;22:345-52. [PMID: 31168337 DOI: 10.22038/ijbms.2019.32399.7765] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
54 Yang Y, Qu A, Zhao R, Hua M, Zhang X, Dong Z, Zheng G, Pan H, Wang H, Yang X, Zhang Y. Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer. Mol Oncol. 2018;12:2072-2084. [PMID: 30242969 DOI: 10.1002/1878-0261.12385] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
55 Darnet S, Moreira FC, Hamoy IG, Burbano R, Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, Assumpção M, Assumpção P, Ribeiro-dos-santos Â. High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential Biomarkers. Bioinform Biol Insights 2015;9s1:BBI.S23773. [DOI: 10.4137/bbi.s23773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
56 Matse JH, Yoshizawa J, Wang X, Elashoff D, Bolscher JG, Veerman EC, Leemans CR, Pegtel DM, Wong DT, Bloemena E. Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms. PLoS One 2015;10:e0142264. [PMID: 26544193 DOI: 10.1371/journal.pone.0142264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
57 Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco A, Roccaro AM, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller E, Trippa L, Ghobrial IM. Prognostic role of circulating exosomal miRNAs in multiple myeloma. Blood. 2017;129:2429-2436. [PMID: 28213378 DOI: 10.1182/blood-2016-09-742296] [Cited by in Crossref: 131] [Cited by in F6Publishing: 136] [Article Influence: 26.2] [Reference Citation Analysis]
58 Ma X, Chen L, Yang Y, Zhang W, Wang P, Zhang K, Zheng B, Zhu L, Sun Z, Zhang S, Guo Y, Liang M, Wang H, Tian J. An Artificial Intelligent Signal Amplification System for in vivo Detection of miRNA. Front Bioeng Biotechnol 2019;7:330. [PMID: 31824932 DOI: 10.3389/fbioe.2019.00330] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
59 Mushtaq F, Zhang J, Li J. miR-144 suppresses cell proliferation and invasion in gastric cancer through downregulation of activating enhancer-binding protein 4. Oncol Lett 2019;17:5686-92. [PMID: 31186793 DOI: 10.3892/ol.2019.10214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
60 Chen Z, Liu S, Xia Y, Wu K. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA. Med Sci Monit 2016;22:4679-91. [PMID: 27904131 DOI: 10.12659/msm.898399] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
61 Yang Z, OuYang X, Zheng L, Dai L, Luo W. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis. Bioengineered 2021;12:1012-25. [PMID: 33464142 DOI: 10.1080/21655979.2021.1876320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
62 Satolli MA, Buffoni L, Spadi R, Roato I. Gastric cancer: The times they are a-changin’. World J Gastrointest Oncol 2015; 7(11): 303-316 [PMID: 26600930 DOI: 10.4251/wjgo.v7.i11.303] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
63 Byrnes KA, Phatak P, Mansour D, Xiao L, Zou T, Rao JN, Turner DJ, Wang JY, Donahue JM. Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). Oncotarget 2016;7:8756-70. [PMID: 26717044 DOI: 10.18632/oncotarget.6752] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
64 Xu YJ, Fan Y. MiR-215/192 participates in gastric cancer progression. Clin Transl Oncol. 2015;17:34-40. [PMID: 24981590 DOI: 10.1007/s12094-014-1194-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
65 Xu M, Jin H, Xu CX, Bi WZ, Wang Y. MiR-34c inhibits osteosarcoma metastasis and chemoresistance. Med Oncol 2014;31:972. [PMID: 24802328 DOI: 10.1007/s12032-014-0972-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
66 Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, Mathé EA, Takenoshita S, Yokota J, Haugen A, Harris CC. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 2011;17:1875-82. [PMID: 21350005 DOI: 10.1158/1078-0432.CCR-10-2961] [Cited by in Crossref: 143] [Cited by in F6Publishing: 82] [Article Influence: 13.0] [Reference Citation Analysis]
67 Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D, Krzeminski P, Ticona FV, Paíno T, Delgado M, Aires A, Ocio EM, García-Sanz R. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica. 2013;98:640-648. [PMID: 23100276 DOI: 10.3324/haematol.2012.070011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
68 Papadaki C, Stoupis G, Tsalikis L, Monastirioti A, Papadaki M, Maliotis N, Stratigos M, Mastrostamatis G, Mavroudis D, Agelaki S. Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer. Oncotarget 2019;10:966-81. [PMID: 30847025 DOI: 10.18632/oncotarget.26629] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
69 Gulley ML. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med. 2015;47:e134. [PMID: 25613731 DOI: 10.1038/emm.2014.93] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
70 Pan X, Zhao T, Mu S, Li S. miR-193a Directly Targets PSEN1 and Inhibits Gastric Cancer Cell Growth, the Activation of PI3K/Akt Signaling Pathway, and the Epithelial-to-Mesenchymal Transition. J Oncol 2021;2021:2804478. [PMID: 34335753 DOI: 10.1155/2021/2804478] [Reference Citation Analysis]
71 Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, Pinatel E, Stadler MB, Provero P, Bernengo MG, Osman I, Taverna D. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011;30:1990-2007. [PMID: 21468029 DOI: 10.1038/emboj.2011.102] [Cited by in Crossref: 183] [Cited by in F6Publishing: 176] [Article Influence: 16.6] [Reference Citation Analysis]
72 Huang J, Gao K, Lin J, Wang Q. MicroRNA-100 inhibits osteosarcoma cell proliferation by targeting Cyr61. Tumour Biol. 2014;35:1095-1100. [PMID: 24317814 DOI: 10.1007/s13277-013-1146-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
73 Budd WT, Seashols-Williams SJ, Clark GC, Weaver D, Calvert V, Petricoin E, Dragoescu EA, O'Hanlon K, Zehner ZE. Dual Action of miR-125b As a Tumor Suppressor and OncomiR-22 Promotes Prostate Cancer Tumorigenesis. PLoS One 2015;10:e0142373. [PMID: 26544868 DOI: 10.1371/journal.pone.0142373] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
74 Vidal AF, Cruz AM, Magalhães L, Pereira AL, Anaissi AK, Alves NC, Albuquerque PJ, Burbano RM, Demachki S, Ribeiro-dos-Santos Â. hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. World J Gastroenterol 2016; 22(6): 2060-2070 [PMID: 26877610 DOI: 10.3748/wjg.v22.i6.2060] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
75 Ren C, Wang W, Han C, Chen H, Fu D, Luo Y, Yao H, Wang D, Ma L, Zhou L, Han D, Shen M. Expression and prognostic value of miR-92a in patients with gastric cancer. Tumour Biol 2016;37:9483-91. [PMID: 26790436 DOI: 10.1007/s13277-016-4865-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
76 Wang J, Sun Z, Yan S, Gao F. Effect of miR‑145 on gastric cancer cells. Mol Med Rep 2019;19:3403-10. [PMID: 30864704 DOI: 10.3892/mmr.2019.10015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
77 Zhu J, Wang H, Xu S, Hao Y. Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis. Oncotarget 2017;8:100478-89. [PMID: 29245994 DOI: 10.18632/oncotarget.19001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
78 Ding B, Gao X, Li H, Liu L, Hao X. A novel microRNA signature predicts survival in stomach adenocarcinoma. Oncotarget 2017;8:28144-53. [PMID: 28423653 DOI: 10.18632/oncotarget.15961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
79 Song J, Bai Z, Zhang J, Meng H, Cai J, Deng W, Bi J, Ma X, Zhang Z. Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis. Oncol Lett. 2013;6:1733-1737. [PMID: 24260069 DOI: 10.3892/ol.2013.1626] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
80 Asadi M, Shanehbandi D, Zafari V, Khaze V, Somi MH, Hashemzadeh S. Transcript Level of MicroRNA Processing Elements in Gastric Cancer. J Gastrointest Cancer 2019;50:855-9. [PMID: 30168106 DOI: 10.1007/s12029-018-0154-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
81 Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011;53:26-33. [PMID: 21546856 DOI: 10.1097/MPG.0b013e31822200cc] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Sun S, Ma J, Xie P, Wu Z, Tian X. Hypoxia-responsive miR-141-3p is involved in the progression of breast cancer via mediating the HMGB1/HIF-1α signaling pathway. J Gene Med 2020;22:e3230. [PMID: 32436353 DOI: 10.1002/jgm.3230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
83 Pietrus M, Seweryn M, Kapusta P, Wołkow P, Pityński K, Wątor G. Low Expression of miR-375 and miR-190b Differentiates Grade 3 Patients with Endometrial Cancer. Biomolecules 2021;11:274. [PMID: 33668431 DOI: 10.3390/biom11020274] [Reference Citation Analysis]
84 Bou Kheir T, Futoma-Kazmierczak E, Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B, Lund AH, Friis-Hansen L. miR-449 inhibits cell proliferation and is down-regulated in gastric cancer. Mol Cancer 2011;10:29. [PMID: 21418558 DOI: 10.1186/1476-4598-10-29] [Cited by in Crossref: 145] [Cited by in F6Publishing: 158] [Article Influence: 13.2] [Reference Citation Analysis]
85 Liu FY, Wang LP, Wang Q, Han P, Zhuang WP, Li MJ, Yuan H. miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer. Cancer Med 2016;5:2302-13. [PMID: 27465546 DOI: 10.1002/cam4.818] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
86 Gu J, Li X, Li H, Jin Z, Jin J. MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer. Biosci Rep 2019;39:BSR20181258. [PMID: 31138759 DOI: 10.1042/BSR20181258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
87 Chen W, Tang Z, Sun Y, Zhang Y, Wang X, Shen Z, Liu F, Qin X. miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Exp Ther Med. 2012;3:351-356. [PMID: 22969895 DOI: 10.3892/etm.2011.411] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
88 Wu Y, Tao L, Liang J, Qiao Y, Liu W, Yu H, Yu X, Liu L. miR-187-3p increases gemcitabine sensitivity in breast cancer cells by targeting FGF9 expression. Exp Ther Med 2020;20:952-60. [PMID: 32765654 DOI: 10.3892/etm.2020.8770] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Jia L, Wu J, Zhang L, Chen J, Zhong D, Xu S, Xie C, Cai J. Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer. PLoS One 2013;8:e58637. [PMID: 23554909 DOI: 10.1371/journal.pone.0058637] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
90 Zhang J, Yang X, Li M, Huang X, Liu C, Gao Z. [Expression of microRNA-191 in T lymphoblastic leukemia/lymphoma and its underlying mechanism]. Zhonghua Xue Ye Xue Za Zhi 2016;37:273-7. [PMID: 27093985 DOI: 10.3760/cma.j.issn.0253-2727.2016.04.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Benetatos L, Hatzimichael E, Londin E, Vartholomatos G, Loher P, Rigoutsos I, Briasoulis E. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci. 2013;70:795-814. [PMID: 22825660 DOI: 10.1007/s00018-012-1080-8] [Cited by in Crossref: 177] [Cited by in F6Publishing: 171] [Article Influence: 17.7] [Reference Citation Analysis]
92 Gao C, Pang M, Zhou Z, Long S, Dong D, Yang J, Cao M, Zhang C, Han S, Li L. Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer. Clin Exp Med. 2015;15:469-475. [PMID: 25398664 DOI: 10.1007/s10238-014-0320-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
93 Zhang S, Yue W, Xie Y, Liu L, Li S, Dang W, Xin S, Yang L, Zhai X, Cao P, Lu J. The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients. Oncol Rep 2019;42:1767-80. [PMID: 31545473 DOI: 10.3892/or.2019.7316] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
94 Lei W, Yan C, Ya J, Yong D, Yujun B, Kai L. MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4. BMC Cancer 2018;18:631. [PMID: 29866054 DOI: 10.1186/s12885-018-4460-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
95 Cheung HH, Davis AJ, Lee TL, Pang AL, Nagrani S, Rennert OM, Chan WY. Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene. 2011;30:3404-3415. [PMID: 21383689 DOI: 10.1038/onc.2011.60] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 8.7] [Reference Citation Analysis]
96 Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X, Li H, Ji R, Guo Q, Zhou Y. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol Lett 2015;10:329-36. [PMID: 26171025 DOI: 10.3892/ol.2015.3179] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
97 Gorur A, Balci Fidanci S, Dogruer Unal N, Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS, Tamer L. Determination of plasma microRNA for early detection of gastric cancer. Mol Biol Rep. 2013;40:2091-2096. [PMID: 23212612 DOI: 10.1007/s11033-012-2267-7] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
98 Qiu F, Sun R, Deng N, Guo T, Cao Y, Yu Y, Wang X, Zou B, Zhang S, Jing T. miR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression. PLoS One. 2015;10:e0120969. [PMID: 25786138 DOI: 10.1371/journal.pone.0120969] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
99 Dou D, Shi YF, Liu Q, Luo J, Liu JX, Liu M, Liu YY, Li YL, Qiu XD, Tan HY. Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1World J Gastroenterol 2018; 24(5): 573-582 [PMID: 29434446 DOI: 10.3748/wjg.v24.i5.573] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
100 Wang T, Ji R, Liu G, Ma B, Wang Z, Wang Q. Lactate induces aberration in the miR-30a-DBF4 axis to promote the development of gastric cancer and weakens the sensitivity to 5-Fu. Cancer Cell Int 2021;21:602. [PMID: 34758839 DOI: 10.1186/s12935-021-02291-2] [Reference Citation Analysis]
101 Zhong J, Huang R, Su Z, Zhang M, Xu M, Gong J, Chen N, Zeng H, Chen X, Zhou Q. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. Oncotarget 2017;8:83523-38. [PMID: 29137361 DOI: 10.18632/oncotarget.18315] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
102 Zhou C, Cui F, Li J, Wang D, Wei Y, Wu Y, Wang J, Zhu H, Wang S. MiR-650 represses high-risk non-metastatic colorectal cancer progression via inhibition of AKT2/GSK3β/E-cadherin pathway. Oncotarget 2017;8:49534-47. [PMID: 28548936 DOI: 10.18632/oncotarget.17743] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
103 Ma HB, Wang S, Wei KF, Sun XL. Survival status of patients with gastric cancer after radical resection: a five-year follow-up study. Shijie Huaren Xiaohua Zazhi 2010; 18(27): 2920-2924 [DOI: 10.11569/wcjd.v18.i27.2920] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Song J, Gao L, Yang G, Tang S, Xie H, Wang Y, Wang J, Zhang Y, Jin J, Gou Y, Yang Z, Chen Z, Wu K, Liu J, Fan D. MiR-199a regulates cell proliferation and survival by targeting FZD7. PLoS One 2014;9:e110074. [PMID: 25313882 DOI: 10.1371/journal.pone.0110074] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
105 Cho JY. Molecular diagnosis for personalized target therapy in gastric cancer. J Gastric Cancer. 2013;13:129-135. [PMID: 24156032 DOI: 10.5230/jgc.2013.13.3.129] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
106 Du J, Liang Y, Li J, Zhao JM, Wang ZN, Lin XY. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN. Front Oncol 2020;10:326. [PMID: 32232005 DOI: 10.3389/fonc.2020.00326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
107 Li Y, Lauriola M, Kim D, Francesconi M, D'Uva G, Shibata D, Malafa MP, Yeatman TJ, Coppola D, Solmi R, Cheng JQ. Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer. Oncogene 2016;35:4558-68. [PMID: 26804172 DOI: 10.1038/onc.2015.522] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
108 Yamamoto H, Watanabe Y, Sato Y, Maehata T, Itoh F. Non-Invasive Early Molecular Detection of Gastric Cancers. Cancers (Basel) 2020;12:E2880. [PMID: 33036473 DOI: 10.3390/cancers12102880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
109 Jin L, Ma X, Zhang N, Zhang Q, Chen X, Zhang Z, Ding G, Yu H. Targeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer. Cancer Manag Res 2021;13:8599-609. [PMID: 34815714 DOI: 10.2147/CMAR.S332713] [Reference Citation Analysis]
110 Ma Z, Ma Y, Xia Q, Li Y, Li R, Chang W, Chen J, Leng Z, Tao K. MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1. J Cancer Res Clin Oncol. 2016;142:1201-1212. [PMID: 26955820 DOI: 10.1007/s00432-016-2139-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
111 Huang L, Xu A, Li T, Han W, Wu S, Wang Y. Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances. Med Oncol. 2013;30:651. [PMID: 23820956 DOI: 10.1007/s12032-013-0651-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
112 Xie Y, Ma X, Chen L, Li H, Gu L, Gao Y, Zhang Y, Li X, Fan Y, Chen J, Zhang X. MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis. Sci Rep 2017;7:5619. [PMID: 28717125 DOI: 10.1038/s41598-017-05801-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
113 Yu J, Wang R, Chen J, Wu J, Dang Z, Zhang Q, Li B. miR-340 Inhibits Proliferation and Induces Apoptosis in Gastric Cancer Cell Line SGC-7901, Possibly via the AKT Pathway. Med Sci Monit 2017;23:71-7. [PMID: 28057912 DOI: 10.12659/msm.898449] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
114 Xie T, Liang J, Guo R, Liu N, Noble PW, Jiang D. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiol Genomics 2011;43:479-87. [PMID: 21266501 DOI: 10.1152/physiolgenomics.00222.2010] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 7.0] [Reference Citation Analysis]
115 Wang JL, Ling ZQ. Progress in research of gastric signet ring cell carcinoma. Shijie Huaren Xiaohua Zazhi 2017; 25(4): 358-363 [DOI: 10.11569/wcjd.v25.i4.358] [Reference Citation Analysis]
116 Mei JW, Yang ZY, Xiang HG, Bao R, Ye YY, Ren T, Wang XF, Shu YJ. MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer 2019;19:740. [PMID: 31357957 DOI: 10.1186/s12885-019-5929-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
117 Fan XD, Luo Y, Wang J, An N. miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer. Biosci Rep 2020;40:BSR20193158. [PMID: 31820783 DOI: 10.1042/BSR20193158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
118 Li YJ, Dong M, Kong FM, Zhou JP, Liang D, Xue HZ. MicroRNA-371-5p targets SOX2 in gastric cancer. Oncotarget 2016;7:31993-2005. [PMID: 27015119 DOI: 10.18632/oncotarget.8289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
119 Fang Y, Fang D, Hu J. MicroRNA and its roles in esophageal cancer. Med Sci Monit. 2012;18:RA22-RA30. [PMID: 22367141 DOI: 10.12659/msm.882509] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
120 Crone SG, Jacobsen A, Federspiel B, Bardram L, Krogh A, Lund AH, Friis-Hansen L. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71. [PMID: 22992343 DOI: 10.1186/1476-4598-11-71] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.6] [Reference Citation Analysis]
121 He Y, Luo Y, Liang B, Ye L, Lu G, He W. Potential applications of MEG3 in cancer diagnosis and prognosis. Oncotarget 2017;8:73282-95. [PMID: 29069869 DOI: 10.18632/oncotarget.19931] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 10.6] [Reference Citation Analysis]
122 Wei S, Dai S, Zhang C, Zhao R, Zhao Z, Song Y, Shan B, Zhao L. LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex. Front Oncol 2021;11:721604. [PMID: 34900675 DOI: 10.3389/fonc.2021.721604] [Reference Citation Analysis]
123 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
124 Wang X, Zhang H, Bai M, Ning T, Ge S, Deng T, Liu R, Zhang L, Ying G, Ba Y. Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer. Mol Ther. 2018;26:774-783. [PMID: 29456019 DOI: 10.1016/j.ymthe.2018.01.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 16.5] [Reference Citation Analysis]
125 Li R, Hu Z, Wang Z, Zhu T, Wang G, Gao B, Wang J, Deng X. miR-125a-5p promotes gastric cancer growth and invasion by regulating the Hippo pathway. J Clin Lab Anal 2021;:e24078. [PMID: 34708891 DOI: 10.1002/jcla.24078] [Reference Citation Analysis]
126 Pan Z, Tian Y, Niu G, Cao C. The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity. Stem Cells Int 2019;2019:8071842. [PMID: 31885627 DOI: 10.1155/2019/8071842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Ou L, Lin H, Song Y, Tan G, Gui X, Li J, Chen X, Deng Z, Lin S. Efficient miRNA Inhibitor with GO-PEI Nanosheets for Osteosarcoma Suppression by Targeting PTEN. Int J Nanomedicine 2020;15:5131-46. [PMID: 32764941 DOI: 10.2147/IJN.S257084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Zhang T, Liu C, Huang S, Ma Y, Fang J, Chen Y. A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer. Gastroenterol Res Pract 2017;2017:1526981. [PMID: 28546810 DOI: 10.1155/2017/1526981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
129 Chen B, Huang T, Jiang J, Lv L, Li H, Xia S. miR-141 suppresses proliferation and motility of gastric cancer cells by targeting HDGF. Mol Cell Biochem. 2014;388:211-218. [PMID: 24276755 DOI: 10.1007/s11010-013-1912-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
130 Zare A, Ganji M, Omrani MD, Alipoor B, Ghaedi H. Gastric Cancer MicroRNAs Meta-signature. Int J Mol Cell Med 2019;8:94-102. [PMID: 32215261 DOI: 10.22088/IJMCM.BUMS.8.2.94] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
131 Sisic L, Vallböhmer D, Stoecklein NH, Blank S, Schmidt T, Driemel C, Möhlendick B, Knoefel WT, Odenthal M, Ott K. Serum microRNA profiles as prognostic or predictive markers in the multimodality treatment of patients with gastric cancer. Oncol Lett 2015;10:869-74. [PMID: 26622585 DOI: 10.3892/ol.2015.3341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
132 Al-Eryani L, Jenkins SF, States VA, Pan J, Malone JC, Rai SN, Galandiuk S, Giri AK, States JC. miRNA expression profiles of premalignant and malignant arsenic-induced skin lesions. PLoS One 2018;13:e0202579. [PMID: 30114287 DOI: 10.1371/journal.pone.0202579] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
133 Milagro FI, Miranda J, Portillo MP, Fernandez-Quintela A, Campión J, Martínez JA. High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS One 2013;8:e54319. [PMID: 23335998 DOI: 10.1371/journal.pone.0054319] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
134 Budhu A, Wang XW. MicroRNAs and Gastroenterological Cancers. Drug Discov Today Dis Mech 2011;8:e95-e102. [PMID: 22582080 DOI: 10.1016/j.ddmec.2011.11.005] [Reference Citation Analysis]
135 Li J, Jin H, Wang X. Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol. 2014;2014:464015. [PMID: 24729878 DOI: 10.1155/2014/464015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
136 Jin Z, Jiang W, Wang L. Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review). Oncol Lett. 2015;9:1502-1508. [PMID: 25788990 DOI: 10.3892/ol.2015.2959] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 8.3] [Reference Citation Analysis]
137 Valenzuela MA, Canales J, Corvalán AH, Quest AF. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol 2015; 21(45): 12742-12756 [PMID: 26668499 DOI: 10.3748/wjg.v21.i45.12742] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
138 Zhao L, Fong AHW, Liu N, Cho WCS. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis. J Biomed Sci 2018;25:16. [PMID: 29455649 DOI: 10.1186/s12929-018-0417-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
139 Li Q, Lu C, Wang J, Gao M, Gao W. MicroRNA-449b-5p Suppresses Proliferation, Migration, and Invasion of Osteosarcoma by Targeting c-Met. Med Sci Monit 2019;25:6236-43. [PMID: 31425497 DOI: 10.12659/MSM.918454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
140 Agnes A, Estrella JS, Badgwell B. The significance of a nineteenth century definition in the era of genomics: linitis plastica. World J Surg Oncol 2017;15:123. [PMID: 28679451 DOI: 10.1186/s12957-017-1187-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
141 Yu X, Luo L, Wu Y, Yu X, Liu Y, Yu X, Zhao X, Zhang X, Cui L, Ye G. Gastric juice miR-129 as a potential biomarker for screening gastric cancer. Med Oncol. 2013;30:365. [PMID: 23307240 DOI: 10.1007/s12032-012-0365-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
142 Maugeri-Saccà M, Pizzuti L, Sergi D, Barba M, Belli F, Fattoruso S, Giannarelli D, Amodio A, Boggia S, Vici P. FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort. J Exp Clin Cancer Res. 2013;32:67. [PMID: 24330513 DOI: 10.1186/1756-9966-32-67] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
143 Sun S, Wang X, Xu X, Di H, Du J, Xu B, Wang Q, Wang J. MiR-433-3p suppresses cell growth and enhances chemosensitivity by targeting CREB in human glioma. Oncotarget 2017;8:5057-68. [PMID: 27926502 DOI: 10.18632/oncotarget.13789] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]
144 Huang Z, Liang H, Chen L. RAB43 Promotes Gastric Cancer Cell Proliferation and Metastasis via Regulating the PI3K/AKT Signaling Pathway. Onco Targets Ther 2020;13:2193-202. [PMID: 32210585 DOI: 10.2147/OTT.S237356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
145 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
146 Ghasemkhani N, Shadvar S, Masoudi Y, Talaei AJ, Yahaghi E, Goudarzi PK, Shakiba E. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Diagn Pathol 2015;10:164. [PMID: 26377406 DOI: 10.1186/s13000-015-0393-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
147 Fujita T, Yanagihara K, Takeshita F, Aoyagi K, Nishimura T, Takigahira M, Chiwaki F, Fukagawa T, Katai H, Ochiya T, Sakamoto H, Konno H, Yoshida T, Sasaki H. Intraperitoneal delivery of a small interfering RNA targeting NEDD1 prolongs the survival of scirrhous gastric cancer model mice. Cancer Sci 2013;104:214-22. [PMID: 23106787 DOI: 10.1111/cas.12054] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
148 Ma J, Xu M, Yin M, Hong J, Chen H, Gao Y, Xie C, Shen N, Gu S, Mo X. Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma. Front Oncol 2019;9:459. [PMID: 31249805 DOI: 10.3389/fonc.2019.00459] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
149 Tian SB, Yu JC, Liu YQ, Kang WM, Ma ZQ, Ye X, Yan C. MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol 2015; 21(31): 9337-9347 [PMID: 26309359 DOI: 10.3748/wjg.v21.i31.9337] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
150 Yang H, Peng Z, Liang M, Zhang Y, Wang Y, Huang T, Jiang Y, Jiang B, Wang Y. The miR-17-92 cluster/QKI2/β-catenin axis promotes osteosarcoma progression. Oncotarget 2018;9:25285-93. [PMID: 29861871 DOI: 10.18632/oncotarget.23935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
151 Sun Z, Chen H, Han Z, Huang W, Hu Y, Zhao M, Lin T, Yu J, Liu H, Jiang Y, Li G. Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature. Front Genet 2020;11:835. [PMID: 32849822 DOI: 10.3389/fgene.2020.00835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa SI, Matsuo Y, Hosoya K, Yamashita M, Taniguchi H, Nosho K, Suzuki H, Yasuda H, Shinomura Y, Itoh F. An updated review of gastric cancer in the next-generation sequencing era: Insights from bench to bedside and vice versaWorld J Gastroenterol 2014; 20(14): 3927-3937 [PMID: 24744582 DOI: 10.3748/wjg.v20.i14.3927] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
153 Streleckiene G, Inciuraite R, Juzenas S, Salteniene V, Steponaitiene R, Gyvyte U, Kiudelis G, Leja M, Ruzgys P, Satkauskas S, Kupcinskiene E, Franke S, Thon C, Link A, Kupcinskas J, Skieceviciene J. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model. Int J Mol Sci 2020;21:E877. [PMID: 32013265 DOI: 10.3390/ijms21030877] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
154 Tang SY, Zhou PJ, Meng Y, Zeng FR, Deng GT. Gastric cancer: An epigenetic view. World J Gastrointest Oncol 2022; 14(1): 90-109 [DOI: 10.4251/wjgo.v14.i1.90] [Reference Citation Analysis]
155 Greither T, Wedler A, Rot S, Keßler J, Kehlen A, Holzhausen HJ, Bache M, Würl P, Taubert H, Kappler M. CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients. Int J Mol Sci 2017;18:E2648. [PMID: 29215551 DOI: 10.3390/ijms18122648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
156 Zhu ED, Li N, Li BS, Li W, Zhang WJ, Mao XH, Guo G, Zou QM, Xiao B. miR-30b, down-regulated in gastric cancer, promotes apoptosis and suppresses tumor growth by targeting plasminogen activator inhibitor-1. PLoS One. 2014;9:e106049. [PMID: 25170877 DOI: 10.1371/journal.pone.0106049] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
157 Luo F, Wu Y, Ding Q, Yuan Y, Jia W. Rs884225 polymorphism is associated with primary hypertension by compromising interaction between epithelial growth factor receptor (EGFR) and miR-214. J Cell Mol Med 2021;25:3714-23. [PMID: 33635564 DOI: 10.1111/jcmm.15976] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Ziari K, Zarea M, Gity M, Fayyaz AF, Yahaghi E, Darian EK, Hashemian AM. Downregulation of miR-148b as biomarker for early detection of hepatocellular carcinoma and may serve as a prognostic marker. Tumour Biol 2016;37:5765-8. [PMID: 26206498 DOI: 10.1007/s13277-015-3777-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
159 Yang Z, Tsuchiya H, Zhang Y, Hartnett ME, Wang L. MicroRNA-433 inhibits liver cancer cell migration by repressing the protein expression and function of cAMP response element-binding protein. J Biol Chem 2013;288:28893-9. [PMID: 23979134 DOI: 10.1074/jbc.M113.502682] [Cited by in Crossref: 60] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
160 Lim SM, Lim JY, Cho JY. Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome. World J Gastroenterol 2014; 20(8): 2042-2050 [PMID: 24587678 DOI: 10.3748/wjg.v20.i8.2042] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
161 Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo-Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther 2014;15:1444-55. [PMID: 25482951 DOI: 10.4161/15384047.2014.955442] [Cited by in Crossref: 136] [Cited by in F6Publishing: 132] [Article Influence: 19.4] [Reference Citation Analysis]
162 Ren W, Li W, Wang D, Hu S, Suo J, Ying X. Combining multi-dimensional data to identify key genes and pathways in gastric cancer. PeerJ 2017;5:e3385. [PMID: 28603669 DOI: 10.7717/peerj.3385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
163 Jiang J, Zheng X, Xu X, Zhou Q, Yan H, Zhang X, Lu B, Wu C, Ju J. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One. 2011;6:e23271. [PMID: 21876743 DOI: 10.1371/journal.pone.0023271] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 4.5] [Reference Citation Analysis]
164 Kim YH, Liang H, Liu X, Lee JS, Cho JY, Cheong JH, Kim H, Li M, Downey TJ, Dyer MD. AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancer. Cancer Res. 2012;72:2512-2521. [PMID: 22434430 DOI: 10.1158/0008-5472.can-11-3870] [Cited by in Crossref: 70] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
165 Xie Y, Wei RR, Huang GL, Zhang MY, Yuan YF, Wang HY. Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma. Med Oncol 2014;31:844. [PMID: 24464213 DOI: 10.1007/s12032-014-0844-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
166 Chan YC, Roy S, Huang Y, Khanna S, Sen CK. The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 2012;287:41032-43. [PMID: 23060436 DOI: 10.1074/jbc.M112.413294] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
167 Jiang JX, Gao S, Wang M, Li X, Sun CY. Identification of differentially expressed microRNAs in pancreatic cancer stem cells. Shijie Huaren Xiaohua Zazhi 2012; 20(34): 3354-3360 [DOI: 10.11569/wcjd.v20.i34.3354] [Reference Citation Analysis]
168 Jiang Y, Zhang M, Guo T, Yang C, Zhang C, Hao J. MicroRNA-21-5p promotes proliferation of gastric cancer cells through targeting SMAD7. Onco Targets Ther 2018;11:4901-11. [PMID: 30147341 DOI: 10.2147/OTT.S163771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
169 Zhang X, Nie Y, Li X, Wu G, Huang Q, Cao J, Du Y, Li J, Deng R, Huang D. MicroRNA-181a functions as an oncomir in gastric cancer by targeting the tumour suppressor gene ATM. Pathol Oncol Res. 2014;20:381-389. [PMID: 24531888 DOI: 10.1007/s12253-013-9707-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
170 Zhang Y, Fan KJ, Sun Q, Chen AZ, Shen WL, Zhao ZH, Zheng XF, Yang X. Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res. 2012;40:9286-9297. [PMID: 22821565 DOI: 10.1093/nar/gks667] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
171 Lordick F. To resect or not resect in metastatic gastric cancer: that is the question! Gastric Cancer 2012;15:229-31. [PMID: 22282136 DOI: 10.1007/s10120-011-0136-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
172 Ding K, Tan S, Huang X, Wang X, Li X, Fan R, Zhu Y, Lobie PE, Wang W, Wu Z. GSE1 predicts poor survival outcome in gastric cancer patients by SLC7A5 enhancement of tumor growth and metastasis. J Biol Chem 2018;293:3949-64. [PMID: 29367342 DOI: 10.1074/jbc.RA117.001103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
173 Zhao X, He L, Li T, Lu Y, Miao Y, Liang S, Guo H, Bai M, Xie H, Luo G. SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer. Cell Death Differ. 2014;21:1900-1913. [PMID: 25080937 DOI: 10.1038/cdd.2014.109] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 7.5] [Reference Citation Analysis]
174 Srivastava A, Goldberger H, Dimtchev A, Ramalinga M, Chijioke J, Marian C, Oermann EK, Uhm S, Kim JS, Chen LN, Li X, Berry DL, Kallakury BV, Chauhan SC, Collins SP, Suy S, Kumar D. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. PLoS One 2013;8:e76994. [PMID: 24167554 DOI: 10.1371/journal.pone.0076994] [Cited by in Crossref: 108] [Cited by in F6Publishing: 112] [Article Influence: 12.0] [Reference Citation Analysis]
175 Wang S, Wang X, Li J, Meng S, Liang Z, Xu X, Zhu Y, Li S, Wu J, Xu M, Ji A, Lin Y, Liu B, Zheng X, Xie B, Xie L. c-Met, CREB1 and EGFR are involved in miR-493-5p inhibition of EMT via AKT/GSK-3β/Snail signaling in prostate cancer. Oncotarget 2017;8:82303-13. [PMID: 29137265 DOI: 10.18632/oncotarget.19398] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
176 Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67:129-139. [PMID: 20981514 DOI: 10.1007/s13105-010-0050-6] [Cited by in Crossref: 392] [Cited by in F6Publishing: 385] [Article Influence: 32.7] [Reference Citation Analysis]
177 Guo X, Xia J, Yan J. Promoter methylated microRNAs: potential therapeutic targets in gastric cancer. Mol Med Rep. 2015;11:759-765. [PMID: 25351138 DOI: 10.3892/mmr.2014.2780] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
178 He Z, Li Z, Zhang X, Yin K, Wang W, Xu Z, Li B, Zhang L, Xu J, Sun G, Wang L, Li Q, Huang X, Zhang L, Zhang D, Xu H, Xu Z. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. Cell Death Dis 2018;9:505. [PMID: 29725130 DOI: 10.1038/s41419-018-0564-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
179 Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One. 2014;9:e85205. [PMID: 24465504 DOI: 10.1371/journal.pone.0085205] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
180 Lu X, Chen F, Liu X, Yuan D, Zi Y, He X, Zhu D. Detection and clinical significance of DNA repair gene ERCC8 tag SNPs in gastric cancer. Turk J Gastroenterol 2018;29:392-6. [PMID: 30249552 DOI: 10.5152/tjg.2018.17662] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
181 Liu Y, Wang C, Li J, Zhu J, Zhao C, Xu H. Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer. Front Pharmacol 2021;12:633453. [PMID: 33981224 DOI: 10.3389/fphar.2021.633453] [Reference Citation Analysis]
182 Wang Z, Yin H, Zhang Y, Feng Y, Yan Z, Jiang X, Bukhari I, Iqbal F, Cooke HJ, Shi Q. miR-214-mediated downregulation of RNF8 induces chromosomal instability in ovarian cancer cells. Cell Cycle 2014;13:3519-28. [PMID: 25483088 DOI: 10.4161/15384101.2014.958413] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
183 Zhu A, Xia J, Zuo J, Jin S, Zhou H, Yao L, Huang H, Han Z. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer. Med Oncol. 2012;29:2701-2709. [PMID: 22167392 DOI: 10.1007/s12032-011-0134-3] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 5.2] [Reference Citation Analysis]
184 Tan Z, Jiang H, Wu Y, Xie L, Dai W, Tang H, Tang S. miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol Cell Biochem. 2014;386:223-231. [PMID: 24352663 DOI: 10.1007/s11010-013-1860-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
185 Matsuo M, Nakada C, Tsukamoto Y, Noguchi T, Uchida T, Hijiya N, Matsuura K, Moriyama M. MiR-29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2. Mol Cancer. 2013;12:15. [PMID: 23442884 DOI: 10.1186/1476-4598-12-15] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
186 Shi M, Mu Y, Zhang H, Liu M, Wan J, Qin X, Li C. MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis. Medicine (Baltimore) 2018;97:e11505. [PMID: 30095616 DOI: 10.1097/MD.0000000000011505] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
187 Xiao Y, Deng T, Su C, Shang Z. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol Lett 2017;13:4986-94. [PMID: 28599501 DOI: 10.3892/ol.2017.6076] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
188 Wang G, Liu G, Ye Y, Fu Y, Zhang X. Upregulation of miR-34a by diallyl disulfide suppresses invasion and induces apoptosis in SGC-7901 cells through inhibition of the PI3K/Akt signaling pathway. Oncol Lett 2016;11:2661-7. [PMID: 27073535 DOI: 10.3892/ol.2016.4266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
189 Gao M, Yin H, Fei ZW. Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 2013; 19(13): 2019-2027 [PMID: 23599620 DOI: 10.3748/wjg.v19.i13.2019] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
190 Tang S, Cheng J, Yao Y, Lou C, Wang L, Huang X, Zhang Y. Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer. Front Genet 2020;11:237. [PMID: 32256526 DOI: 10.3389/fgene.2020.00237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
191 Azam AT, Bahador R, Hesarikia H, Shakeri M, Yeganeh A. Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma. Tumour Biol 2016;37:5769-73. [PMID: 26224480 DOI: 10.1007/s13277-015-3821-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
192 Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K, Baba H. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer. 2012;106:182-188. [PMID: 22108521 DOI: 10.1038/bjc.2011.509] [Cited by in Crossref: 96] [Cited by in F6Publishing: 95] [Article Influence: 8.7] [Reference Citation Analysis]
193 Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM, Germoni S. miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis. 2012;3:e423. [PMID: 23152059 DOI: 10.1038/cddis.2012.160] [Cited by in Crossref: 124] [Cited by in F6Publishing: 120] [Article Influence: 12.4] [Reference Citation Analysis]
194 Juzėnas S, Saltenienė V, Kupcinskas J, Link A, Kiudelis G, Jonaitis L, Jarmalaite S, Kupcinskas L, Malfertheiner P, Skieceviciene J. Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. PLoS One 2015;10:e0132327. [PMID: 26172537 DOI: 10.1371/journal.pone.0132327] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
195 Chang W, Wang J, Tao D, Zhang Y, He J, Shi C. Identification of a novel miRNA from the ovine ovary by a combinatorial approach of bioinformatics and experiments. J Vet Med Sci 2016;77:1617-24. [PMID: 26268666 DOI: 10.1292/jvms.15-0289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
196 Tong YQ, Liu B, Zheng HY, Gu J, Liu H, Li F, Tan BH, Hartman M, Song C, Li Y. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma. Oncotarget 2015;6:25024-33. [PMID: 26317904 DOI: 10.18632/oncotarget.4622] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
197 Shin VY, Siu MT, Liu X, Ng EKO, Kwong A, Chu KM. MiR-92 suppresses proliferation and induces apoptosis by targeting EP4/Notch1 axis in gastric cancer. Oncotarget 2018;9:24209-20. [PMID: 29849934 DOI: 10.18632/oncotarget.24819] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
198 Morini SR, Denadai MV, Waisberg J, Lopes Filho GJ, Matos D, Saad SS. Metalloproteinases and colorectal cancer. Correlation of gene expression and clinical-pathological parameters. Acta Cir Bras 2020;35:e202000707. [PMID: 32813775 DOI: 10.1590/s0102-865020200070000007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Yang R, Xu X, Li H, Chen J, Xiang X, Dong Z, Zhang D. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Sci Rep 2017;7:43409. [PMID: 28240316 DOI: 10.1038/srep43409] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
200 Hirata K, Suzuki H, Imaeda H, Matsuzaki J, Tsugawa H, Nagano O, Asakura K, Saya H, Hibi T. CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence. Br J Cancer. 2013;109:379-386. [PMID: 23778530 DOI: 10.1038/bjc.2013.314] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 8.9] [Reference Citation Analysis]
201 Lin Y, Zhai E, Liao B, Xu L, Zhang X, Peng S, He Y, Cai S, Zeng Z, Chen M. Autocrine VEGF signaling promotes cell proliferation through a PLC-dependent pathway and modulates Apatinib treatment efficacy in gastric cancer. Oncotarget 2017;8:11990-2002. [PMID: 28061477 DOI: 10.18632/oncotarget.14467] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
202 Rokavec M, Li H, Jiang L, Hermeking H. The p53/microRNA connection in gastrointestinal cancer. Clin Exp Gastroenterol 2014;7:395-413. [PMID: 25328413 DOI: 10.2147/CEG.S43738] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
203 Liu Z, Sun F, Hong Y, Liu Y, Fen M, Yin K, Ge X, Wang F, Chen X, Guan W. MEG2 is regulated by miR-181a-5p and functions as a tumour suppressor gene to suppress the proliferation and migration of gastric cancer cells. Mol Cancer 2017;16:133. [PMID: 28747184 DOI: 10.1186/s12943-017-0695-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
204 Weiner-Gorzel K, Dempsey E, Milewska M, McGoldrick A, Toh V, Walsh A, Lindsay S, Gubbins L, Cannon A, Sharpe D, O'Sullivan J, Murphy M, Madden SF, Kell M, McCann A, Furlong F. Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells. Cancer Med 2015;4:745-58. [PMID: 25684390 DOI: 10.1002/cam4.409] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 12.1] [Reference Citation Analysis]
205 Huang J, He Y, Mcleod HL, Xie Y, Xiao D, Hu H, Chen P, Shen L, Zeng S, Yin X, Ge J, Li L, Tang L, Ma J, Chen Z. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer. BMC Cancer 2017;17:886. [PMID: 29273006 DOI: 10.1186/s12885-017-3875-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
206 Du G, Yu X, Chen Y, Cai W. MiR-1-3p Suppresses Colorectal Cancer Cell Proliferation and Metastasis by Inhibiting YWHAZ-Mediated Epithelial-Mesenchymal Transition. Front Oncol 2021;11:634596. [PMID: 33718221 DOI: 10.3389/fonc.2021.634596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
207 Wei J, Meng G, Wu J, Wang Y, Zhang Q, Dong T, Bao J, Wang C, Zhang J. MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA. Bioengineered 2021. [PMID: 34696659 DOI: 10.1080/21655979.2021.1993718] [Reference Citation Analysis]
208 Wang J, Zhang X, Wang L, Yang Y, Dong Z, Wang H, Du L, Wang C. MicroRNA-214 suppresses oncogenesis and exerts impact on prognosis by targeting PDRG1 in bladder cancer. PLoS One. 2015;10:e0118086. [PMID: 25706919 DOI: 10.1371/journal.pone.0118086] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
209 Sousa JF, Nam KT, Petersen CP, Lee HJ, Yang HK, Kim WH, Goldenring JR. miR-30-HNF4γ and miR-194-NR2F2 regulatory networks contribute to the upregulation of metaplasia markers in the stomach. Gut 2016;65:914-24. [PMID: 25800782 DOI: 10.1136/gutjnl-2014-308759] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
210 Zeng W, Zhang S, Yang L, Wei W, Gao J, Guo N, Wu F. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer. BMC Med Genet 2020;21:28. [PMID: 32041551 DOI: 10.1186/s12881-020-0967-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
211 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
212 Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Lee JS, Cho JY. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol 2013; 19(41): 7078-7088 [PMID: 24222951 DOI: 10.3748/wjg.v19.i41.7078] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
213 Li Y, Tian Z, Tan Y, Lian G, Chen S, Chen S, Li J, Li X, Huang K, Chen Y. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer. Mol Cancer 2020;19:109. [PMID: 32580736 DOI: 10.1186/s12943-020-01229-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
214 Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma. Cancer. 2013;119:1985-1993. [PMID: 23456798 DOI: 10.1002/cncr.28002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
215 Ertao Z, Jianhui C, Chuangqi C, Changjiang Q, Sile C, Yulong H, Hui W, Shirong C. Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway. J Exp Clin Cancer Res 2016;35:63. [PMID: 27039174 DOI: 10.1186/s13046-016-0336-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
216 Zhang Z, Li Y, Fan L, Zhao Q, Tan B, Li Z, Zang A. microRNA-425-5p is upregulated in human gastric cancer and contributes to invasion and metastasis in vitro and in vivo. Exp Ther Med. 2015;9:1617-1622. [PMID: 26136868 DOI: 10.3892/etm.2015.2318] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
217 Lin Y, Zeng Y, Zhang F, Xue L, Huang Z, Li W, Guo M. Characterization of microRNA expression profiles and the discovery of novel microRNAs involved in cancer during human embryonic development. PLoS One 2013;8:e69230. [PMID: 23936320 DOI: 10.1371/journal.pone.0069230] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
218 Gotanda K, Hirota T, Matsumoto N, Ieiri I. MicroRNA-433 negatively regulates the expression of thymidylate synthase (TYMS) responsible for 5-fluorouracil sensitivity in HeLa cells. BMC Cancer 2013;13:369. [PMID: 23915286 DOI: 10.1186/1471-2407-13-369] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
219 Zaman MS, Maher DM, Khan S, Jaggi M, Chauhan SC. Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. J Ovarian Res 2012;5:44. [PMID: 23237306 DOI: 10.1186/1757-2215-5-44] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
220 Fujita T, Chiwaki F, Takahashi RU, Aoyagi K, Yanagihara K, Nishimura T, Tamaoki M, Komatsu M, Komatsuzaki R, Matsusaki K, Ichikawa H, Sakamoto H, Yamada Y, Fukagawa T, Katai H, Konno H, Ochiya T, Yoshida T, Sasaki H. Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PLoS One. 2015;10:e0130808. [PMID: 26110809 DOI: 10.1371/journal.pone.0130808] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
221 Ma MH, An JX, Zhang C, Liu J, Liang Y, Zhang CD, Zhang Z, Dai DQ. ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression. Cancer Cell Int 2019;19:27. [PMID: 30774556 DOI: 10.1186/s12935-019-0742-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
222 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
223 Shimizu T, Sohn Y, Choi E, Petersen CP, Prasad N, Goldenring JR. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation. Cell Mol Gastroenterol Hepatol 2020;9:61-78. [PMID: 31473306 DOI: 10.1016/j.jcmgh.2019.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
224 Zheng J, Liu Y, Qiao Y, Zhang L, Lu S. miR-103 Promotes Proliferation and Metastasis by Targeting KLF4 in Gastric Cancer. Int J Mol Sci 2017;18:E910. [PMID: 28445396 DOI: 10.3390/ijms18050910] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
225 Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017;3:348-58. [PMID: 28462377 DOI: 10.1016/j.jcmgh.2017.02.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
226 Hui C, Tian L, He X. Circular RNA circNHSL1 Contributes to Gastric Cancer Progression Through the miR-149-5p/YWHAZ Axis. Cancer Manag Res 2020;12:7117-30. [PMID: 32848466 DOI: 10.2147/CMAR.S253152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
227 Yan L, You WQ, Sheng NQ, Gong JF, Hu LD, Tan GW, Chen HQ, Wang ZG. A CREB1/miR-433 reciprocal feedback loop modulates proliferation and metastasis in colorectal cancer. Aging (Albany NY) 2018;10:3774-93. [PMID: 30523220 DOI: 10.18632/aging.101671] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
228 Yahya SMM, Yahya SMM. The Effect of miR-98 and miR-214 on Apoptotic and Angiogenic Pathways in Hepatocellular Carcinoma HepG2 Cells. Indian J Clin Biochem 2020;35:353-8. [PMID: 32647414 DOI: 10.1007/s12291-019-00824-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
229 Zhang JX, Xu Y, Gao Y, Chen C, Zheng ZS, Yun M, Weng HW, Xie D, Ye S. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway. Mol Cancer. 2017;16:18. [PMID: 28114937 DOI: 10.1186/s12943-017-0586-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 10.2] [Reference Citation Analysis]
230 Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R, Cao Z, Singh B, Franklin JL, Wang J, Hu H, Wei T, Yang M, Yeatman TJ, Lee E, Saito-Diaz K, Hinger S, Patton JG, Chung CH, Emmrich S, Klusmann JH, Fan D, Coffey RJ. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling. Nat Med 2017;23:1331-41. [PMID: 29035371 DOI: 10.1038/nm.4424] [Cited by in Crossref: 162] [Cited by in F6Publishing: 173] [Article Influence: 32.4] [Reference Citation Analysis]
231 Yu J, Qi J, Sun X, Wang W, Wei G, Wu Y, Gao Q, Zheng J. MicroRNA‑181a promotes cell proliferation and inhibits apoptosis in gastric cancer by targeting RASSF1A. Oncol Rep 2018;40:1959-70. [PMID: 30106448 DOI: 10.3892/or.2018.6632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
232 Inaoka K, Inokawa Y, Nomoto S. Genomic-Wide Analysis with Microarrays in Human Oncology. Microarrays (Basel) 2015;4:454-73. [PMID: 27600234 DOI: 10.3390/microarrays4040454] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
233 Zhang LF, Lou JT, Lu MH, Gao C, Zhao S, Li B, Liang S, Li Y, Li D, Liu MF. Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma. EMBO J 2015;34:2671-85. [PMID: 26346275 DOI: 10.15252/embj.201591803] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 6.4] [Reference Citation Analysis]
234 Sakamoto N, Naito Y, Oue N, Sentani K, Uraoka N, Zarni Oo H, Yanagihara K, Aoyagi K, Sasaki H, Yasui W. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci. 2014;105:236-243. [PMID: 24283384 DOI: 10.1111/cas.12330] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
235 Min J, Han TS, Sohn Y, Shimizu T, Choi B, Bae SW, Hur K, Kong SH, Suh YS, Lee HJ, Kim JS, Min JK, Kim WH, Kim VN, Choi E, Goldenring JR, Yang HK. microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2. Gastric Cancer 2020;23:600-13. [PMID: 32112274 DOI: 10.1007/s10120-020-01052-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
236 Feng Y, Duan F, Liu W, Fu X, Cui S, Yang Z. Prognostic value of the microRNA-214 in multiple human cancers: a meta-analysis of observational studies. Oncotarget 2017;8:75350-60. [PMID: 29088870 DOI: 10.18632/oncotarget.17642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
237 Huang YK, Yu JC. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review. World J Gastroenterol 2015; 21(34): 9863-9886 [PMID: 26379393 DOI: 10.3748/wjg.v21.i34.9863] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
238 Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, Scala E, Fadda P, Cristofoletti C, Facchiano A, Frontani M, Monopoli A, Ferracin M, Negrini M, Lombardo GA, Caprini E, Russo G. MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome. Cell Death Dis 2011;2:e151. [PMID: 21525938 DOI: 10.1038/cddis.2011.32] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 8.5] [Reference Citation Analysis]
239 Zheng Z, Yan D, Chen X, Huang H, Chen K, Li G, Zhou L, Zheng D, Tu L, Dong XD. MicroRNA-206: Effective Inhibition of Gastric Cancer Progression through the c-Met Pathway. PLoS One 2015;10:e0128751. [PMID: 26186594 DOI: 10.1371/journal.pone.0128751] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
240 Ren C, Chen H, Han C, Fu D, Wang F, Wang D, Ma L, Zhou L, Han D. The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer. Oncotarget 2016;7:36655-65. [PMID: 27166269 DOI: 10.18632/oncotarget.9131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
241 Amin MMJ, Trevelyan CJ, Turner NA. MicroRNA-214 in Health and Disease. Cells 2021;10:3274. [PMID: 34943783 DOI: 10.3390/cells10123274] [Reference Citation Analysis]
242 Li N, Han M, Zhou N, Tang Y, Tang XS. MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2). Med Sci Monit 2018;24:5960-72. [PMID: 30147110 DOI: 10.12659/MSM.909458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
243 Lu WD, Zuo Y, Xu Z, Zhang M. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. World J Gastroenterol 2015; 21(15): 4564-4573 [PMID: 25914465 DOI: 10.3748/wjg.v21.i15.4564] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
244 Meng F, Dai E, Yu X, Zhang Y, Chen X, Liu X, Wang S, Wang L, Jiang W. Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease. J R Soc Interface 2014;11:20131057. [PMID: 24352679 DOI: 10.1098/rsif.2013.1057] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
245 Li RD, Han GX, Li W, Tao KX. Down-regulation of microRNA-433 expression in gastric cancer: Possible mechanisms involved. Shijie Huaren Xiaohua Zazhi 2012; 20(19): 1726-1731 [DOI: 10.11569/wcjd.v20.i19.1726] [Reference Citation Analysis]
246 Lee JW, Guan W, Han S, Hong DK, Kim LS, Kim H. MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer. Cancer Sci 2018;109:1404-13. [PMID: 29575368 DOI: 10.1111/cas.13588] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
247 Wang Y, Zeng J, Pan J, Geng X, Liu Y, Wu J, Song P, Wang Y, Jia J, Wang L. MicroRNA-200c is involved in proliferation of gastric cancer by directly repressing p27Kip1. Biochem Biophys Rep 2016;8:227-33. [PMID: 28955960 DOI: 10.1016/j.bbrep.2016.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
248 Ye DM, Xu G, Ma W, Li Y, Luo W, Xiao Y, Liu Y, Zhang Z. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett 2020;19:17-29. [PMID: 31897111 DOI: 10.3892/ol.2019.11078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
249 Jin L, Zhang N, Zhang Q, Ding G, Yang Z, Zhang Z. Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients. PeerJ 2020;8:e8943. [PMID: 32328349 DOI: 10.7717/peerj.8943] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
250 Zhang W, Li Y. miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer. Int J Oncol 2016;48:1877-85. [PMID: 26983401 DOI: 10.3892/ijo.2016.3437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
251 Li H, Liu J, Chen J, Wang H, Yang L, Chen F, Fan S, Wang J, Shao B, Yin D, Zeng M, Li M, Li J, Su F, Liu Q, Yao H, Su S, Song E. A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients. Nat Commun 2018;9:1614. [PMID: 29691399 DOI: 10.1038/s41467-018-03537-w] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 12.5] [Reference Citation Analysis]
252 Liu X, Abraham JM, Cheng Y, Wang Z, Wang Z, Zhang G, Ashktorab H, Smoot DT, Cole RN, Boronina TN, DeVine LR, Talbot CC, Liu Z, Meltzer SJ. Synthetic Circular RNA Functions as a miR-21 Sponge to Suppress Gastric Carcinoma Cell Proliferation. Mol Ther Nucleic Acids. 2018;13:312-321. [PMID: 30326427 DOI: 10.1016/j.omtn.2018.09.010] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 16.5] [Reference Citation Analysis]
253 Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, Dai J, Ma H, Hu Z, Shen H, Xu Y, Jin G. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110:2291-2299. [PMID: 24595006 DOI: 10.1038/bjc.2014.119] [Cited by in Crossref: 139] [Cited by in F6Publishing: 142] [Article Influence: 17.4] [Reference Citation Analysis]
254 Guo SL, Ye H, Teng Y, Wang YL, Yang G, Li XB, Zhang C, Yang X, Yang ZZ, Yang X. Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency. Nat Commun. 2013;4:2544. [PMID: 24149576 DOI: 10.1038/ncomms3544] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
255 Zhang X, Peng Y, Jin Z, Huang W, Cheng Y, Liu Y, Feng X, Yang M, Huang Y, Zhao Z. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma. Oncotarget. 2015;6:32878-32889. [PMID: 26460735 DOI: 10.18632/oncotarget.5419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
256 Zheng Y, Wang M, Wang S, Xu P, Deng Y, Lin S, Li N, Liu K, Zhu Y, Zhai Z, Wu Y, Dai Z, Zhu G. LncRNA MEG3 rs3087918 was associated with a decreased breast cancer risk in a Chinese population: a case-control study. BMC Cancer 2020;20:659. [PMID: 32669097 DOI: 10.1186/s12885-020-07145-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
257 Parvizpour S, Hussin N, Shamsir MS, Razmara J. Psychrophilic enzymes: structural adaptation, pharmaceutical and industrial applications. Appl Microbiol Biotechnol 2021;105:899-907. [PMID: 33427934 DOI: 10.1007/s00253-020-11074-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
258 Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2011;1:21. [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
259 Zhang Y, Bai J, Si W, Yuan S, Li Y, Chen X. SLC39A7, regulated by miR-139-5p, induces cell proliferation, migration and inhibits apoptosis in gastric cancer via Akt/mTOR signaling pathway. Biosci Rep 2020;40:BSR20200041. [PMID: 32109290 DOI: 10.1042/BSR20200041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
260 Wang Z, Li Y, Cao J, Zhang W, Wang Q, Zhang Z, Gao Z, Ye Y, Jiang K, Wang S. MicroRNA Profile Identifies miR-6165 Could Suppress Gastric Cancer Migration and Invasion by Targeting STRN4. Onco Targets Ther 2020;13:1859-69. [PMID: 32184620 DOI: 10.2147/OTT.S208024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
261 Duan Q, Wang X, Gong W, Ni L, Chen C, He X, Chen F, Yang L, Wang P, Wang DW. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 2012;7:e31518. [PMID: 22359598 DOI: 10.1371/journal.pone.0031518] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 10.1] [Reference Citation Analysis]
262 Weidhaas J. Using microRNAs to understand cancer biology. Lancet Oncol 2010;11:106-7. [PMID: 20022811 DOI: 10.1016/S1470-2045(09)70386-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
263 Zhang X, Zhang W, Feng LJ. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One 2014;9:e111906. [PMID: 25401500 DOI: 10.1371/journal.pone.0111906] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
264 Chang S, He S, Qiu G, Lu J, Wang J, Liu J, Fan L, Zhao W, Che X. MicroRNA-125b promotes invasion and metastasis of gastric cancer by targeting STARD13 and NEU1. Tumour Biol 2016;37:12141-51. [PMID: 27220320 DOI: 10.1007/s13277-016-5094-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
265 Lehner B, Kunz P, Saehr H, Fellenberg J. Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone. BMC Cancer 2014;14:495. [PMID: 25005035 DOI: 10.1186/1471-2407-14-495] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
266 Sui M, Jiao A, Zhai H, Wang Y, Wang Y, Sun D, Li P. Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer. Exp Ther Med 2017;14:657-63. [PMID: 28672982 DOI: 10.3892/etm.2017.4548] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
267 Zhang X, Li X, Tan Z, Liu X, Yang C, Ding X, Hu X, Zhou J, Xiang S, Zhou C. MicroRNA-373 is upregulated and targets TNFAIP1 in human gastric cancer, contributing to tumorigenesis. Oncol Lett. 2013;6:1427-1434. [PMID: 24179536 DOI: 10.3892/ol.2013.1534] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
268 Li JA, Wang YD, Wang K, Wang ZL, Jia DY, Yang BY, Xiong CB. Downregulation of miR-214-3p May Contribute to Pathogenesis of Ulcerative Colitis via Targeting STAT6. Biomed Res Int 2017;2017:8524972. [PMID: 28752100 DOI: 10.1155/2017/8524972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
269 Zang C, Zhao F, Hua L, Pu Y. The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene. Cancer Cell Int 2018;18:186. [PMID: 30479565 DOI: 10.1186/s12935-018-0689-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
270 Salim MT, Esmerats JF, Arjunon S, Villa-Roel N, Nerem RM, Jo H, Yoganathan AP. miR-214 is Stretch-Sensitive in Aortic Valve and Inhibits Aortic Valve Calcification. Ann Biomed Eng 2019;47:1106-15. [PMID: 30671754 DOI: 10.1007/s10439-019-02206-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
271 Lino Cardenas CL, Henaoui IS, Courcot E, Roderburg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 2013;9:e1003291. [PMID: 23459460 DOI: 10.1371/journal.pgen.1003291] [Cited by in Crossref: 153] [Cited by in F6Publishing: 146] [Article Influence: 17.0] [Reference Citation Analysis]
272 Yin Y, Li J, Chen S, Zhou T, Si J. MicroRNAs as Diagnostic Biomarkers in Gastric Cancer. Int J Mol Sci. 2012;13:12544-12555. [PMID: 23202912 DOI: 10.3390/ijms131012544] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
273 Wang YW, Shi DB, Chen X, Gao C, Gao P. Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour. PLoS One. 2014;9:e91307. [PMID: 24614175 DOI: 10.1371/journal.pone.0091307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
274 Zheng Q, Chen C, Guan H, Kang W, Yu C. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget. 2017;8:46611-46623. [PMID: 28402940 DOI: 10.18632/oncotarget.16679] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
275 Wang YW, Chen X, Ma R, Gao P. Understanding the CREB1-miRNA feedback loop in human malignancies. Tumour Biol 2016;37:8487-502. [PMID: 27059735 DOI: 10.1007/s13277-016-5050-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
276 Wang Z, Ji F. Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21. Oncol Lett. 2018;15:4585-4591. [PMID: 29541229 DOI: 10.3892/ol.2018.7822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
277 Tsujiura M, Komatsu S, Ichikawa D, Shiozaki A, Konishi H, Takeshita H, Moriumura R, Nagata H, Kawaguchi T, Hirajima S. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer. 2015;18:271-279. [PMID: 24626859 DOI: 10.1007/s10120-014-0363-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
278 Qu X, Zhao M, Wu S, Yu W, Xu J, Xu J, Li J, Chen L. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma. Med Oncol 2014;31:219. [PMID: 25216866 DOI: 10.1007/s12032-014-0219-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
279 Shi XB, Xue L, Ma AH, Tepper CG, Kung HJ, White RW. miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 2011;71:538-49. [PMID: 20886540 DOI: 10.1002/pros.21270] [Cited by in Crossref: 139] [Cited by in F6Publishing: 137] [Article Influence: 11.6] [Reference Citation Analysis]
280 Luo SS, Liao XW, Zhu XD. Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma. J Cancer 2019;10:6298-313. [PMID: 31772663 DOI: 10.7150/jca.33250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
281 Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58:706-714. [PMID: 23053883 DOI: 10.1007/s10620-012-2395-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
282 Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM, Zhang X, Jiang L, Xing CZ, Zhang Y. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011;10:1. [PMID: 21205300 DOI: 10.1186/1476-4598-10-1] [Cited by in Crossref: 152] [Cited by in F6Publishing: 138] [Article Influence: 13.8] [Reference Citation Analysis]
283 Lustosa SA, Viana Lde S, Affonso RJ Jr, Silva SR, Denadai MV, de Toledo SR, Oliveira ID, Matos D. Expression profiling using a cDNA array and immunohistochemistry for the extracellular matrix genes FN-1, ITGA-3, ITGB-5, MMP-2, and MMP-9 in colorectal carcinoma progression and dissemination. ScientificWorldJournal 2014;2014:102541. [PMID: 24737953 DOI: 10.1155/2014/102541] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
284 Jin L, Ma XM, Wang TT, Yang Y, Zhang N, Zeng N, Bai ZG, Yin J, Zhang J, Ding GQ, Zhang ZT. Psoralen Suppresses Cisplatin-Mediated Resistance and Induces Apoptosis of Gastric Adenocarcinoma by Disruption of the miR196a-HOXB7-HER2 Axis. Cancer Manag Res 2020;12:2803-27. [PMID: 32368152 DOI: 10.2147/CMAR.S248094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
285 Zhang PF, Sheng LL, Wang G, Tian M, Zhu LY, Zhang R, Zhang J, Zhu JS. miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression. Oncotarget. 2016;7:35284-35292. [PMID: 27167197 DOI: 10.18632/oncotarget.9169] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
286 Zhang Y, Guan DH, Bi RX, Xie J, Yang CH, Jiang YH. Prognostic value of microRNAs in gastric cancer: a meta-analysis. Oncotarget. 2017;8:55489-55510. [PMID: 28903436 DOI: 10.18632/oncotarget.18590] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
287 Han JB, Huang ML, Li F, Yang R, Chen SM, Tao ZZ. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN. Cancer Biother Radiopharm 2020;35:615-25. [PMID: 32101017 DOI: 10.1089/cbr.2019.2978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
288 Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, Santamarina I, Blanco M, Fernández-Tajes J, Quindós M, Carral A, Figueroa A, Antón-Aparicio LM, Calvo L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med 2012;10:186. [PMID: 22954417 DOI: 10.1186/1479-5876-10-186] [Cited by in Crossref: 95] [Cited by in F6Publishing: 94] [Article Influence: 9.5] [Reference Citation Analysis]
289 Feng A, Yuan X, Li X. MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1. Oncol Rep 2017;38:2752-60. [PMID: 29048674 DOI: 10.3892/or.2017.6001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
290 Poursheikhani A, Bahmanpour Z, Razmara E, Mashouri L, Taheri M, Morshedi Rad D, Yousefi H, Bitaraf A, Babashah S. Non-coding RNAs underlying chemoresistance in gastric cancer. Cell Oncol (Dordr) 2020;43:961-88. [PMID: 32495294 DOI: 10.1007/s13402-020-00528-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
291 Okada H, Honda M, Campbell JS, Takegoshi K, Sakai Y, Yamashita T, Shirasaki T, Takabatake R, Nakamura M, Tanaka T, Kaneko S. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice. Cancer Sci 2015;106:1143-52. [PMID: 26122702 DOI: 10.1111/cas.12730] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
292 Yan R, Li K, Yuan DW, Wang HN, Zhang Y, Dang CX, Zhu K. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Int J Oncol 2018;53:2566-78. [PMID: 30320337 DOI: 10.3892/ijo.2018.4595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
293 Yao Q, Gu A, Wang Z, Xue Y. MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2. Exp Ther Med 2018;15:3088-95. [PMID: 29456712 DOI: 10.3892/etm.2018.5763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
294 Hu JY, Yi W, Zhang MY, Xu R, Zeng LS, Long XR, Zhou XM, Zheng XS, Kang Y, Wang HY. MicroRNA-711 is a prognostic factor for poor overall survival and has an oncogenic role in breast cancer. Oncol Lett 2016;11:2155-63. [PMID: 26998141 DOI: 10.3892/ol.2016.4217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
295 Kong X, Qian J, Chen LS, Wang YC, Wang JL, Chen H, Weng YR, Zhao SL, Hong J, Chen YX, Zou W, Xu J, Fang JY. Synbindin in extracellular signal-regulated protein kinase spatial regulation and gastric cancer aggressiveness. J Natl Cancer Inst 2013;105:1738-49. [PMID: 24104608 DOI: 10.1093/jnci/djt271] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
296 Lin Y, Zhao J, Wang H, Cao J, Nie Y. miR-181a modulates proliferation, migration and autophagy in AGS gastric cancer cells and downregulates MTMR3. Mol Med Rep 2017;15:2451-6. [PMID: 28447759 DOI: 10.3892/mmr.2017.6289] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
297 Morais DR, Reis ST, Viana N, Piantino CB, Massoco C, Moura C, Dip N, Silva IA, Srougi M, Leite KR. The involvement of miR-100 in bladder urothelial carcinogenesis changing the expression levels of mRNA and proteins of genes related to cell proliferation, survival, apoptosis and chromosomal stability. Cancer Cell Int 2014;14:119. [PMID: 25493074 DOI: 10.1186/s12935-014-0119-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
298 Cherradi N. microRNAs as Potential Biomarkers in Adrenocortical Cancer: Progress and Challenges. Front Endocrinol (Lausanne) 2015;6:195. [PMID: 26834703 DOI: 10.3389/fendo.2015.00195] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
299 Cui H, Wang L, Gong P, Zhao C, Zhang S, Zhang K, Zhou R, Zhao Z, Fan H. Deregulation between miR-29b/c and DNMT3A is associated with epigenetic silencing of the CDH1 gene, affecting cell migration and invasion in gastric cancer. PLoS One 2015;10:e0123926. [PMID: 25874772 DOI: 10.1371/journal.pone.0123926] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
300 Ou-Yang X, Xia KJ, Chen ZW, Zhu PQ. Advances in research of miR-148a in gastric cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2839-2844 [DOI: 10.11569/wcjd.v22.i20.2839] [Reference Citation Analysis]
301 Li Z, Gu X, Fang Y, Xiang J, Chen Z. microRNA expression profiles in human colorectal cancers with brain metastases. Oncol Lett 2012;3:346-50. [PMID: 22740910 DOI: 10.3892/ol.2011.497] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
302 Denaro M, Navari E, Ugolini C, Seccia V, Donati V, Casani AP, Basolo F. A microRNA signature for the differential diagnosis of salivary gland tumors. PLoS One 2019;14:e0210968. [PMID: 30682201 DOI: 10.1371/journal.pone.0210968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
303 Nair VS, Maeda LS, Ioannidis JP. Clinical outcome prediction by microRNAs in human cancer: a systematic review. J Natl Cancer Inst 2012;104:528-40. [PMID: 22395642 DOI: 10.1093/jnci/djs027] [Cited by in Crossref: 169] [Cited by in F6Publishing: 163] [Article Influence: 16.9] [Reference Citation Analysis]
304 Song J, Bai Z, Han W, Zhang J, Meng H, Bi J, Ma X, Han S, Zhang Z. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig Dis Sci. 2012;57:897-904. [PMID: 22198701 DOI: 10.1007/s10620-011-1981-7] [Cited by in Crossref: 190] [Cited by in F6Publishing: 186] [Article Influence: 17.3] [Reference Citation Analysis]
305 Liu Y, Zhou Y, Gong X, Zhang C. MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor. Exp Ther Med 2017;14:173-80. [PMID: 28672911 DOI: 10.3892/etm.2017.4477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
306 Wei Y, Wang Y, Zang A, Wang Z, Fang G, Hong D. MiR-4766-5p Inhibits The Development And Progression Of Gastric Cancer By Targeting NKAP. Onco Targets Ther 2019;12:8525-36. [PMID: 31802890 DOI: 10.2147/OTT.S220234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
307 Shao C, Wang R, Kong D, Gao Q, Xu C. Identification of potential core genes in gastric cancer using bioinformatics analysis. J Gastrointest Oncol 2021;12:2109-22. [PMID: 34790378 DOI: 10.21037/jgo-21-628] [Reference Citation Analysis]
308 Alessandrini L, Manchi M, De Re V, Dolcetti R, Canzonieri V. Proposed Molecular and miRNA Classification of Gastric Cancer. Int J Mol Sci 2018;19:E1683. [PMID: 29882766 DOI: 10.3390/ijms19061683] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
309 Yun J, Han SB, Kim HJ, Go SI, Lee WS, Bae WK, Cho SH, Song EK, Lee OJ, Kim HK, Yang Y, Kwon J, Chae HB, Lee KH, Han HS. Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites. J Gastric Cancer 2019;19:301-14. [PMID: 31598373 DOI: 10.5230/jgc.2019.19.e27] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
310 Cai H, Yuan Y, Hao YF, Guo TK, Wei X, Zhang YM. Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer. Med Oncol. 2013;30:452. [PMID: 23307259 DOI: 10.1007/s12032-012-0452-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 6.6] [Reference Citation Analysis]
311 Orsenigo E, Kusamura S, Staudacher C. Sentinel lymph node and prognostic factors in gastric cancer. Surg Endosc 2011;25:3715-6. [PMID: 21557000 DOI: 10.1007/s00464-011-1609-1] [Reference Citation Analysis]
312 Suárez-Arriaga MC, Torres J, Camorlinga-Ponce M, Gómez-Delgado A, Piña-Sánchez P, Valdez-Salazar HA, Ribas-Aparicio RM, Fuentes-Pananá EM, Ruiz-Tachiquín ME. A proposed method for the relative quantification of levels of circulating microRNAs in the plasma of gastric cancer patients. Oncol Lett 2017;13:3109-17. [PMID: 28521416 DOI: 10.3892/ol.2017.5816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
313 Shahar T, Granit A, Zrihan D, Canello T, Charbit H, Einstein O, Rozovski U, Elgavish S, Ram Z, Siegal T, Lavon I. Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients. J Neurooncol 2016;130:413-22. [PMID: 27573219 DOI: 10.1007/s11060-016-2248-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
314 Calatayud D, Dehlendorff C, Boisen MK, Hasselby JP, Schultz NA, Werner J, Immervoll H, Molven A, Hansen CP, Johansen JS. Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers. Biomark Res. 2017;5:8. [PMID: 28239461 DOI: 10.1186/s40364-017-0087-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
315 Nalluri JJ, Barh D, Azevedo V, Ghosh P. miRsig: a consensus-based network inference methodology to identify pan-cancer miRNA-miRNA interaction signatures. Sci Rep 2017;7:39684. [PMID: 28045122 DOI: 10.1038/srep39684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
316 Wang JL, Hu Y, Kong X, Wang ZH, Chen HY, Xu J, Fang JY. Candidate microRNA biomarkers in human gastric cancer: a systematic review and validation study. PLoS One. 2013;8:e73683. [PMID: 24040025 DOI: 10.1371/journal.pone.0073683] [Cited by in Crossref: 51] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
317 Qi W, Zhang Q. Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer. PeerJ 2021;9:e10462. [PMID: 33604158 DOI: 10.7717/peerj.10462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
318 Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, Zeng YX, Shao JY. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One 2014;9:e86149. [PMID: 24465927 DOI: 10.1371/journal.pone.0086149] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
319 Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y, Liu B, Yu L, Hou Y. Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer. PLoS One 2012;7:e43268. [PMID: 22937028 DOI: 10.1371/journal.pone.0043268] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
320 Ochiai C, Miyauchi S, Kudo Y, Naruke Y, Yoneyama S, Tomita K, Dongze L, Chiba Y, Hirata TI, Ichijo T, Nagai K, Kobayashi S, Yamada S, Hikono H, Murakami K. Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing. PLoS One 2021;16:e0256588. [PMID: 34506539 DOI: 10.1371/journal.pone.0256588] [Reference Citation Analysis]
321 Rotkrua P, Shimada S, Mogushi K, Akiyama Y, Tanaka H, Yuasa Y. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br J Cancer. 2013;108:932-940. [PMID: 23385731 DOI: 10.1038/bjc.2013.30] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 4.2] [Reference Citation Analysis]
322 Yan HC, Wang HB. Significance of expression of ECT2 in gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(14): 2215-2220 [DOI: 10.11569/wcjd.v23.i14.2215] [Reference Citation Analysis]
323 Song Z, Zhao W, Cao D, Zhang J, Chen S. Elementary screening of lymph node metastatic-related genes in gastric cancer based on the co-expression network of messenger RNA, microRNA and long non-coding RNA. Braz J Med Biol Res 2018;51:e6685. [PMID: 29489999 DOI: 10.1590/1414-431x20176685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
324 Xia JT, Chen LZ, Jian WH, Wang KB, Yang YZ, He WL, He YL, Chen D, Li W. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling. J Transl Med. 2014;12:33. [PMID: 24495516 DOI: 10.1186/1479-5876-12-33] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
325 Zhou J, Cui X, Xiao F, Cai G. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers. Int J Mol Sci 2021;22:1529. [PMID: 33546390 DOI: 10.3390/ijms22041529] [Reference Citation Analysis]
326 Velu VK, Ramesh R, Srinivasan AR. Circulating MicroRNAs as Biomarkers in Health and Disease. J Clin Diagn Res 2012;6:1791-5. [PMID: 23373057 DOI: 10.7860/JCDR/2012/4901.2653] [Cited by in Crossref: 11] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
327 Feng X, Wang Y, Ma Z, Yang R, Liang S, Zhang M, Song S, Li S, Liu G, Fan D. MicroRNA-645, up-regulated in human adencarcinoma of gastric esophageal junction, inhibits apoptosis by targeting tumor suppressor IFIT2. BMC Cancer. 2014;14:633. [PMID: 25174799 DOI: 10.1186/1471-2407-14-633] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
328 Ahadi A. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer. Immunogenetics 2021;73:155-61. [PMID: 33399935 DOI: 10.1007/s00251-020-01201-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
329 Lopez-Serra P, Esteller M. DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene. 2012;31:1609-1622. [PMID: 21860412 DOI: 10.1038/onc.2011.354] [Cited by in Crossref: 243] [Cited by in F6Publishing: 234] [Article Influence: 22.1] [Reference Citation Analysis]
330 Li C, Dong Q, Che X, Xu L, Li Z, Fan Y, Hou K, Wang S, Qu J, Xu L, Wen T, Yang X, Qu X, Liu Y. MicroRNA-29b-2-5p inhibits cell proliferation by directly targeting Cbl-b in pancreatic ductal adenocarcinoma. BMC Cancer 2018;18:681. [PMID: 29940895 DOI: 10.1186/s12885-018-4526-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
331 Huang L, Wang ZY, Pan DD. Penicillin‑binding protein 1A mutation‑positive Helicobacter pylori promotes epithelial‑mesenchymal transition in gastric cancer via the suppression of microRNA‑134. Int J Oncol 2019;54:916-28. [PMID: 30569124 DOI: 10.3892/ijo.2018.4665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
332 Treece AL, Duncan DL, Tang W, Elmore S, Morgan DR, Dominguez RL, Speck O, Meyers MO, Gulley ML. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns. Lab Invest. 2016;96:661-671. [PMID: 26950485 DOI: 10.1038/labinvest.2016.33] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
333 Chen X, Huang Z, Chen R. Microrna-136 promotes proliferation and invasion ingastric cancer cells through Pten/Akt/P-Akt signaling pathway. Oncol Lett 2018;15:4683-9. [PMID: 29541241 DOI: 10.3892/ol.2018.7848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
334 Yang TS, Yang XH, Wang XD, Wang YL, Zhou B, Song ZS. MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int. 2013;13:68. [PMID: 23834902 DOI: 10.1186/1475-2867-13-68] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 11.6] [Reference Citation Analysis]
335 Di Lauro L, Vici P, Belli F, Tomao S, Fattoruso SI, Arena MG, Pizzuti L, Giannarelli D, Paoletti G, Barba M, Sergi D, Maugeri-Saccà M. Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer. Gastric Cancer 2014;17:718-24. [PMID: 24318671 DOI: 10.1007/s10120-013-0321-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
336 Kahroba H, Hejazi MS, Samadi N. Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer. Cell Mol Life Sci. 2019;76:1747-1758. [PMID: 30734835 DOI: 10.1007/s00018-019-03035-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
337 Samukawa E, Fujihara S, Oura K, Iwama H, Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara M, Kobara H, Mori H, Okano K, Suzuki Y, Himoto T, Masaki T. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest. Int J Oncol 2017;51:1674-84. [PMID: 29075786 DOI: 10.3892/ijo.2017.4177] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
338 Peng WZ, Ma R, Wang F, Yu J, Liu ZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci. 2014;15:4031-4048. [PMID: 24603541 DOI: 10.3390/ijms15034031] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
339 Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6:6001-6013. [PMID: 25749389 DOI: 10.18632/oncotarget.3469] [Cited by in Crossref: 389] [Cited by in F6Publishing: 452] [Article Influence: 64.8] [Reference Citation Analysis]
340 Wu F, Lin X, Shan SK, Li F, Xu F, Zhong JY, Guo B, Zheng MH, Wang Y, Mo ZH, Yuan LQ. The Suppression of miR-199a-3p by Promoter Methylation Contributes to Papillary Thyroid Carcinoma Aggressiveness by Targeting RAP2a and DNMT3a. Front Cell Dev Biol 2020;8:594528. [PMID: 33365310 DOI: 10.3389/fcell.2020.594528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
341 Tsai MM, Wang CS, Tsai CY, Huang HW, Chi HC, Lin YH, Lu PH, Lin KH. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016;17:pii: E945. [PMID: 27322246 DOI: 10.3390/ijms17060945] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
342 Deng M, Tang HL, Lu XH, Liu MY, Lu XM, Gu YX, Liu JF, He ZM. miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer. PLoS One. 2013;8:e72662. [PMID: 24015269 DOI: 10.1371/journal.pone.0072662] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
343 Li J, Zhang Z, Hu J, Wan X, Huang W, Zhang H, Jiang N. MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth. Mol Cell Biochem 2021. [PMID: 34870753 DOI: 10.1007/s11010-021-04290-3] [Reference Citation Analysis]
344 Bo X, Chen Y, Sheng W, Gong Y, Wang H, Gao W, Zhang B. The regulation and function of microRNA-377/RASSF8 signaling axis in gastric cancer. Oncol Lett 2018;15:3630-8. [PMID: 29456730 DOI: 10.3892/ol.2018.7740] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
345 Sandoval-Bórquez A, Saavedra K, Carrasco-Avino G, Garcia-Bloj B, Fry J, Wichmann I, Corvalán AH. Noncoding Genomics in Gastric Cancer and the Gastric Precancerous Cascade: Pathogenesis and Biomarkers. Dis Markers 2015;2015:503762. [PMID: 26379360 DOI: 10.1155/2015/503762] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
346 Sun D, Han S, Liu C, Zhou R, Sun W, Zhang Z, Qu J. Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid Carcinoma. Med Sci Monit 2016;22:1210-7. [PMID: 27062921 DOI: 10.12659/msm.895788] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
347 Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu Y, Li C, Su L, Zhu Z. Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer. 2014;13:127. [PMID: 24886316 DOI: 10.1186/1476-4598-13-127] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
348 Liu J, Jennings SF, Tong W, Hong H. Next generation sequencing for profiling expression of miRNAs: technical progress and applications in drug development. J Biomed Sci Eng 2011;4:666-76. [PMID: 22457835 DOI: 10.4236/jbise.2011.410083] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
349 Zhao G, Jiang T, Liu Y, Huai G, Lan C, Li G, Jia G, Wang K, Yang M. Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer. BMC Cancer 2018;18:676. [PMID: 29929476 DOI: 10.1186/s12885-018-4601-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
350 Penna E, Orso F, Taverna D. miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol. 2015;135:960-969. [PMID: 25501033 DOI: 10.1038/jid.2014.479] [Cited by in Crossref: 109] [Cited by in F6Publishing: 110] [Article Influence: 13.6] [Reference Citation Analysis]
351 Guan E, Tian F, Liu Z. A novel risk score model for stomach adenocarcinoma based on the expression levels of 10 genes. Oncol Lett 2020;19:1351-67. [PMID: 31966067 DOI: 10.3892/ol.2019.11190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
352 Jiang C, Chen X, Alattar M, Wei J, Liu H. MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer. Cancer Gene Ther 2015;22:291-301. [DOI: 10.1038/cgt.2015.19] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 8.9] [Reference Citation Analysis]
353 Ren C, Chen H, Han C, Fu D, Wang D, Shen M. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer. J Cancer Res Clin Oncol. 2016;142:2489-2496. [PMID: 27605261 DOI: 10.1007/s00432-016-2243-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
354 Cao D, Jiang J, Tsukamoto T, Liu R, Ma L, Jia Z, Kong F, Oshima M, Cao X. Canolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic mice. PLoS One. 2015;10:e0120938. [PMID: 25781635 DOI: 10.1371/journal.pone.0120938] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
355 Bie LY, Li N, Deng WY, Lu XY, Guo P, Luo SX. Serum miR-191 and miR-425 as Diagnostic and Prognostic Markers of Advanced Gastric Cancer Can Predict the Sensitivity of FOLFOX Chemotherapy Regimen. Onco Targets Ther 2020;13:1705-15. [PMID: 32158234 DOI: 10.2147/OTT.S233086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
356 Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ, Wang Y. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma. Oncotarget. 2014;5:9472-9483. [PMID: 25344865 DOI: 10.18632/oncotarget.2418] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 6.9] [Reference Citation Analysis]
357 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
358 Wu S, Xie J, Shi H, Wang ZW. miR-492 promotes chemoresistance to CDDP and metastasis by targeting inhibiting DNMT3B and induces stemness in gastric cancer. Biosci Rep 2020;40:BSR20194342. [PMID: 32065219 DOI: 10.1042/BSR20194342] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
359 Strickertsson JA, Rasmussen LJ, Friis-Hansen L. Enterococcus faecalis Infection and Reactive Oxygen Species Down-Regulates the miR-17-92 Cluster in Gastric Adenocarcinoma Cell Culture. Genes (Basel) 2014;5:726-38. [PMID: 25170597 DOI: 10.3390/genes5030726] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
360 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]
361 Zhao LX, Zhang K, Shen BB, Li JN. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer. World J Gastrointest Oncol 2021; 13(12): 1981-1996 [DOI: 10.4251/wjgo.v13.i12.1981] [Reference Citation Analysis]
362 Guo LH, Li H, Wang F, Yu J, He JS. The Tumor Suppressor Roles of miR-433 and miR-127 in Gastric Cancer. Int J Mol Sci. 2013;14:14171-14184. [PMID: 23880861 DOI: 10.3390/ijms140714171] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 7.4] [Reference Citation Analysis]
363 Xu X, Wei Y, Wang S, Luo M, Zeng H. Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions. Oncotarget 2017;8:61944-57. [PMID: 28977917 DOI: 10.18632/oncotarget.18734] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
364 Cooke CL, Torres J, Solnick JV. Biomarkers of Helicobacter pylori-associated gastric cancer. Gut Microbes. 2013;4:532-540. [PMID: 23851317 DOI: 10.4161/gmic.25720] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
365 Meireles Da Costa N, Ribeiro Pinto LF, Nasciutti LE, Palumbo A Jr. The Prominent Role of HMGA Proteins in the Early Management of Gastrointestinal Cancers. Biomed Res Int 2019;2019:2059516. [PMID: 31737655 DOI: 10.1155/2019/2059516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
366 Zhang X, Ni Z, Duan Z, Xin Z, Wang H, Tan J, Wang G, Li F. Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis. PLoS One 2015;10:e0116979. [PMID: 25646628 DOI: 10.1371/journal.pone.0116979] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
367 Jang HJ, Lee HS, Burt BM, Lee GK, Yoon KA, Park YY, Sohn BH, Kim SB, Kim MS, Lee JM, Joo J, Kim SC, Yun JS, Na KJ, Choi YL, Park JL, Kim SY, Lee YS, Han L, Liang H, Mak D, Burks JK, Zo JI, Sugarbaker DJ, Shim YM, Lee JS. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut. 2017;66:215-225. [PMID: 27507904 DOI: 10.1136/gutjnl-2015-311238] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
368 Chan E, Prado DE, Weidhaas JB. Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med 2011;17:235-43. [PMID: 21354374 DOI: 10.1016/j.molmed.2011.01.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 5.1] [Reference Citation Analysis]
369 Mitsuhashi K, Yamamoto I, Kurihara H, Kanno S, Ito M, Igarashi H, Ishigami K, Sukawa Y, Tachibana M, Takahashi H, Tokino T, Maruyama R, Suzuki H, Imai K, Shinomura Y, Yamamoto H, Nosho K. Analysis of the molecular features of rectal carcinoid tumors to identify new biomarkers that predict biological malignancy. Oncotarget 2015;6:22114-25. [PMID: 26090613 DOI: 10.18632/oncotarget.4294] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
370 Gigante M, Pontrelli P, Herr W, Gigante M, D'Avenia M, Zaza G, Cavalcanti E, Accetturo M, Lucarelli G, Carrieri G, Battaglia M, Storkus WJ, Gesualdo L, Ranieri E. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. J Transl Med 2016;14:84. [PMID: 27063186 DOI: 10.1186/s12967-016-0841-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
371 Shi S, Li D, Li Y, Feng Z, Du Y, Nie Y. LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer. Exp Ther Med 2020;19:569-78. [PMID: 31853323 DOI: 10.3892/etm.2019.8226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
372 Deng Y, Zhou X, Xiang X, Ou Y, He J. Effect of miRNA-19a on gastrointestinal motility in rats with functional dyspepsia. Exp Ther Med 2018;15:4875-9. [PMID: 29805508 DOI: 10.3892/etm.2018.6009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
373 Gu S, Chan WY. Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a. Int J Mol Sci 2012;13:8449-66. [PMID: 22942713 DOI: 10.3390/ijms13078449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
374 Vishnubalaji R, Elango R, Manikandan M, Siyal AA, Ali D, Al-Rikabi A, Hamam D, Hamam R, Benabdelkamel H, Masood A, Alanazi IO, Alfadda AA, Alfayez M, Aldahmash A, Kassem M, Alajez NM. MicroRNA-3148 acts as molecular switch promoting malignant transformation and adipocytic differentiation of immortalized human bone marrow stromal cells via direct targeting of the SMAD2/TGFβ pathway. Cell Death Discov 2020;6:79. [PMID: 32922961 DOI: 10.1038/s41420-020-00312-z] [Reference Citation Analysis]
375 Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 2011;4:79. [PMID: 22112324 DOI: 10.1186/1755-8794-4-79] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
376 Ajdarkosh H, Dadpay M, Yahaghi E, Pirzaman ER, Fayyaz AF, Darian EK, Mokarizadeh A. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues. Diagn Pathol 2015;10:135. [PMID: 26248880 DOI: 10.1186/s13000-015-0371-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
377 Li S, Zhu J, Li J, Li S, Li B. MicroRNA-141 inhibits proliferation of gastric cardia adenocarcinoma by targeting MACC1. Arch Med Sci 2018;14:588-96. [PMID: 29765447 DOI: 10.5114/aoms.2017.68757] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
378 Tie J, Zhang X, Fan D. Epigenetic roles in the malignant transformation of gastric mucosal cells. Cell Mol Life Sci 2016;73:4599-610. [PMID: 27464701 DOI: 10.1007/s00018-016-2308-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
379 Liu X, Kwong A, Sihoe A, Chu KM. Plasma miR-940 may serve as a novel biomarker for gastric cancer. Tumour Biol 2016;37:3589-97. [PMID: 26456959 DOI: 10.1007/s13277-015-4019-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
380 Guo PH, Du YL, Nie YQ. Expression of miR-191 and its potential target genes in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2012; 20(25): 2347-2352 [DOI: 10.11569/wcjd.v20.i25.2347] [Reference Citation Analysis]
381 Attallah O, Karthikesalingam A, Holt PJE, Thompson MM, Sayers R, Bown MJ, Choke EC, Ma X. Feature selection through validation and un-censoring of endovascular repair survival data for predicting the risk of re-intervention. BMC Med Inform Decis Mak 2017;17:115. [PMID: 28774329 DOI: 10.1186/s12911-017-0508-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
382 Duan Y, Hu L, Liu B, Yu B, Li J, Yan M, Yu Y, Li C, Su L, Zhu Z. Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer. 2014;13:127. [PMID: 24886316 DOI: 10.1007/s11033-013-2871-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
383 Zou J, Xu Y. MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4. Med Sci Monit. 2016;22:2243-2252. [PMID: 27353653 DOI: 10.12659/msm.896633] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
384 Yu T, Wang LN, Li W, Zuo QF, Li MM, Zou QM, Xiao B. Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4. Cancer Sci 2018;109:1393-403. [PMID: 29569792 DOI: 10.1111/cas.13583] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
385 Luo Y, Zhang C, Tang F, Zhao J, Shen C, Wang C, Yu P, Wang M, Li Y, Di JI. Bioinformatics identification of potentially involved microRNAs in Tibetan with gastric cancer based on microRNA profiling. Cancer Cell Int. 2015;15:115. [PMID: 26692821 DOI: 10.1186/s12935-015-0266-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
386 Guo LM, Ding GF, Xu W, Ge H, Jiang Y, Chen XJ, Lu Y. MiR-135a-5p represses proliferation of HNSCC by targeting HOXA10. Cancer Biol Ther 2018;19:973-83. [PMID: 29580143 DOI: 10.1080/15384047.2018.1450112] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
387 Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, Hirakawa K, Yasui W. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2014;105:228-235. [PMID: 24283360 DOI: 10.1111/cas.12329] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
388 Yao Q, Tu C, Lu D, Zou Y, Liu H, Zhang S. Clinicopathological significance of the microRNA-146a/WASP-family verprolin-homologous protein-2 axis in gastric cancer. Cancer Sci 2017;108:1285-92. [PMID: 28387985 DOI: 10.1111/cas.13254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
389 Li H, Cheng J, Mao Y, Jiang M, Fan X. miR-21 inhibits the effects of cyclooxygenase-2 inhibitor NS398 on apoptosis and invasion in gastric cancer cells. Onco Targets Ther 2015;8:3245-53. [PMID: 26604791 DOI: 10.2147/OTT.S90012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
390 Xu X, Yang X, Xing C, Zhang S, Cao J. miRNA: The nemesis of gastric cancer (Review). Oncol Lett. 2013;6:631-641. [PMID: 24137382 DOI: 10.3892/ol.2013.1428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
391 Xu G, Zhu H, Zhang M, Xu J. Histone deacetylase 3 is associated with gastric cancer cell growth via the miR-454-mediated targeting of CHD5. Int J Mol Med 2018;41:155-63. [PMID: 29115379 DOI: 10.3892/ijmm.2017.3225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
392 Vidal AF, Ribeiro-Dos-Santos AM, Vinasco-Sandoval T, Magalhães L, Pinto P, Anaissi AKM, Demachki S, de Assumpção PP, Dos Santos SEB, Ribeiro-Dos-Santos Â. The comprehensive expression analysis of circular RNAs in gastric cancer and its association with field cancerization. Sci Rep 2017;7:14551. [PMID: 29109417 DOI: 10.1038/s41598-017-15061-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
393 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]